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PROFILING THE ANTIVIRAL SMALL RNA RESPONSE IN MOSQUITOES TO ARBOVIRUS INFECTION: 
INTRA- AND INTERSPECIES COMPARISONS AND RELATIONSHIP TO VECTOR COMPETENCE 
 
 
 Arthropod-borne viruses (arboviruses) are a taxonomically diverse group of viruses 
which represent emerging/re-emerging threats to global human and livestock health. By far, 
the most prevalent vectors of arboviruses are mosquitoes, though ticks and sandflies are also 
significant vectors for viruses causing human disease. Since the discovery of Aedes aegypti as 
the primary vector for yellow fever virus in the early 1900’s, an astounding amount of money 
and effort has been expended on trying to control arbovirus transmission. For most of this time, 
efforts have primarily focused on controlling vector mosquito populations, with variable results. 
With the advancement of molecular biology, much knowledge has been gained on how viruses 
infect, replicate within, and are eventually transmitted by their arthropod vectors. However, we 
still lack a detailed understanding of how mosquitoes control arbovirus infection and mitigate 
pathogenesis.  
 Unlike vertebrates, mosquitoes and other invertebrates lack adaptive immune systems, 
as well as many of the important innate immune effectors vertebrates possess to combat viral 
infection. However, mosquitoes do possess sophisticated mechanisms for dealing with 
microbial infection. RNA interference (RNAi) is the major innate immune response in 
mosquitoes to virus infection. Work over the past nearly 20 years has illustrated the importance 
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of RNAi pathways in controlling arbovirus infection; however, many unanswered questions 
regarding RNAi and its role in vector/virus ecology remain.  
 Accordingly, this dissertation focused on investigating the role of two RNAi pathways, 
the small interfering RNA (siRNA) pathway, and the PIWI-interacting RNA (piRNA) pathway, in 
controlling West Nile virus (WNV) infection in Culex spp. mosquitoes. We first began by 
performing a comparative analysis of the antiviral small RNA response in field-collected Culex 
spp. mosquitoes to WNV to colonized strains of Culex mosquitoes. Utilizing next-generation 
sequencing technology, we sequenced viral-derived small RNA populations corresponding to 
products of both the siRNA and piRNA pathways and made both intra- and interspecies 
comparisons in the targeting of the virus genome by these pathways. Doing so, we were able to 
find a remarkable amount of conservation in the targeting of the virus genome by the siRNA 
pathway between several species and populations within species, but also found that Cx. 
quinquefasciatus mosquitoes exhibited a unique targeting profile of the virus genome by this 
pathway. We also found 24-30 nucleotide RNAs, consistent in size with products of the piRNA 
pathway, were produced in significantly different proportions amongst different mosquito 
species/populations. 
 This led us to further investigate the role of the piRNA pathway during arbovirus 
infection. We analyzed piRNA populations from Cx. tarsalis mosquitoes infected with either 
flaviviruses (i.e. WNV) or alphaviruses (i.e. Western equine encephalitis virus, Sindbis virus) and 
looked for characteristic signatures of the “ping-pong” dependent amplification loop, a model 
proposed for the biogenesis of piRNAs. In congruence with published studies on flavivirus 
infection in mosquitoes, but in contrast to published studies on alphavirus infection in 
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mosquitoes, we found no signatures of ping-pong dependent amplification in any of the virus 
infection models of Cx. tarsalis. After further analysis and comparison to a small RNA library 
sequenced from alphavirus Ae. aegypti mosquitoes, we concluded that the differential 
biogenesis of viral-derived piRNA-like small RNAs in response to arbovirus infection in 
mosquitoes is dependent upon the vector-virus pairing. 
 Lastly, we sought to determine the effect of RNAi on either restricting or permitting 
virus escape from the midgut of mosquitoes. Using multiple biological replicates and sampling 
over numerous time points, we sequenced small RNA populations from WNV-infected Cx. 
quinquefasciatus mosquitoes. We found that neither the siRNA nor piRNA pathways appear to 
be functionally active at early points during infection, which are arguably the most important 
for virus in establishing an infection. Surprisingly, we found no association between the siRNA 
targeting profiles of the virus genome and the infection phenotype, i.e. midgut restriction or 
midgut escape.  
 The studies included in this dissertation show a large degree of intra- and interspecies 
conservation of viral genome targeting by the exogenous siRNA pathway, with the notable 
exception of Cx. quinquefasciatus, which exhibited a high degree of intraspecies correlation, but 
differed from the other species studied in this regard. Secondly, we provided evidence 
suggesting that biogenesis and/or processing of viral-derived piRNA-like small RNAs is 
differentially modulated depending on the virus-vector pairing. Lastly, we found no evidence 
for the early induction of the siRNA or piRNA pathways following peroral exposure to WNV, and 
that once initiated, these pathways collectively fail to restrict the virus from disseminating from  
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the midgut. Taken together, the studies entailed in this dissertation  contribute to the rapidly 
expanding body of knowledge regarding the antiviral function of RNAi pathways in controlling 
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Arthropod-borne viruses (arboviruses) represent a taxonomically diverse group of 
viruses that persist in nature through transmission cycles between hematophagous arthropod 
vectors and vertebrate hosts [1]. Known arboviruses belong to seven different families: 
Flaviviridae, Togaviridae, Bunyaviridae, Rhabdoviridae, Reoviridae, a single genus from 
Orthomyxoviridae (Thogotovirus), and the sole genus/species from Asfarviridae (Asfivirus, 
African swine fever virus, ASFV) [2]. With the exception of Asfarviridae, which possesses a 
double-stranded DNA (dsDNA) genome [3], all other arboviruses have RNA genomes, though 
the polarity, single or double-strandedness, presence of one or multiple segments, and 
organization of the genome differs between families. As of April 2014, there are 637 viruses 
listed in “The International Catalog of Arboviruses Including Certain Other Viruses of 
Vertebrates” [4], of which at least 214 are known or probable arboviruses, at least 287 are 
possible arboviruses, and the remainder are probably or definitely not arboviruses [1] (these 
numbers have likely increased). 
Arbovirus infection is a serious emerging/re-emerging threat globally to both human 
and livestock health. Several billion people, primarily living in tropical, underdeveloped, and 
impoverished nations are currently at risk of infection from one or more arboviruses, with 
perhaps hundreds of millions of infections occurring annually from dengue viruses (DENV, 
Flaviviridae) alone [5]. Largely due to globalization, numerous arboviruses, such as West Nile 
virus (WNV, Flaviviridae) and chikungunya virus (CHIKV, Togaviridae) have expanded their 
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geographic ranges dramatically. Most recently, as of April 2014, local transmission of CHIKV has 
occurred in several Caribbean nations, starting in Saint Martin in December 2013 and quickly 
spreading to other countries, marking the first instances of autochthonous transmission of this 
virus in Western hemisphere [6]. In addition, climate change resulting in the geographic 
expansion of arthropod vector species is also expected to significantly contribute to the 
increase of arbovirus prevalence [7, 8]. Increasing global temperatures may also result in 
increased disease transmission by reducing the extrinsic incubation period (EIP) required by 
arboviruses to replicate in and be transmitted by their arthropod vectors [9]. Finally, the 
importation of a large variety of domestic and exotic animals for the agriculture and pet trades 
may contribute to the transfer of arboviruses to non-endemic regions [10]. 
Prevention of arbovirus transmission has historically and presently primarily relied upon 
vector control strategies; in the case of mosquitoes, by far the most prevalent vectors of 
arbovirus disease, larvacide treatment and adulticide treatments are common preventative 
measures. However, failure to maintain adequate mosquito control programs, along with other 
factors such as urbanization, insecticide and drug resistance, and genetic adaptation by 
pathogens has resulted in the emergence/resurgence of arbovirus diseases [11]. More modern 
experimental approaches to curbing arbovirus transmission include sterile insect technique [12-
14] and the related “Trojan female technique” [15], development of a variety of transgenic 
mosquitoes incapable of virus transmission [16-22], and the use of Wolbachia (Rickettsiales), a 
maternally-inherited Gram negative insect endosymbiont bacterium, to reduce mosquito 
lifespans below the threshold of most arbovirus EIPs or to block transmission of arboviruses 
[23-29]. With regards to generation of transgenic mosquitoes, these efforts have greatly 
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benefitted from the full genome sequencing of three medically important mosquito species: the 
yellow fever mosquito (Aedes aegypti), the southern house mosquito (Culex quinquefasciatus), 
and the malaria mosquito (Anopheles gambiae) [30-32]. 
 
Flaviviridae and the genus Flavivirus 
The Flaviviridae are a large family of viruses comprised of four genera: Flavivirus, 
Pestivirus, Hepacivirus, and the newly accepted Pegivirus [33, 34]. All members of Flaviviridae 
possess a lipid-bilayer enveloped nucleocapsid housing a single-stranded, positive sense RNA 
genome [35], though the genes encoded vary by genus.  The RNA genome serves as the viral 
mRNA, and is thus infectious to cells [36], and is 5’-m7GpppAp capped and lacks poly(A) tailing 
at the 3’ terminus [37, 38]. Genomic RNA is translated into a single polyprotein precursor which 
is co- and post-translationally cleaved into individual proteins by both viral encoded and host 
proteases. Structural proteins are encoded at the N-terminal region of the polyprotein, while 
non-structural (NS) proteins make up the remainder. Out of the four genera, only the genus 
Flavivirus is known to contain members transmitted by arthropod vectors. 
The genus Flavivirus is comprised of over 70 species of viruses [39], most of which are 
arboviruses or insect-specific viruses. Members of the genus Flavivirus include YFV, DENV, West 
Nile virus (WNV), Japanese encephalitis virus (JEV), St. Louis encephalitis virus (SLEV), and tick-
borne encephalitis virus (TBEV), among others. The name of the genus is derived from the Latin 
word flavus, meaning “yellow”, describing the jaundice caused in infected, symptomatic 
persons by the type species, yellow-fever virus (YFV). YFV itself holds a special place in the 
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annals of virology, being the first virus, or “filterable agent”, shown to be responsible for a 
human disease [40]. 
Flavivirus genomes are ~11 kilobases (kb) in length, and contains three structural 
proteins in the 5’- portion (Capsid, C; pre-membrane, prM; envelope, E) and seven NS proteins 
making up the rest of the genome (NS1, NS2a, NS2b, NS3, NS4a, NS4b, NS5). The mature virion 
is a small, spherical particle of ~50 nanometers (nm) in diameter with a ~30 nm electron dense 
core surrounded by a lipid bilayer envelope [41]. Flaviviruses enter cells via binding of cellular 
receptors and entry into clathrin-coated pits resulting in endocytosis (receptors implicated in 
cellular entry in both mosquitoes and mammals are discussed in greater detail in the 
“Pathogenesis in Mosquitoes and Mammals” section) [42, 43]. Virions are uncoated via a 
conformational change in the E glycoprotein from a homodimeric to a trimeric structure in low 
pH endosomes, resulting in fusion of the viral and cellular membranes and release of the viral 
nucleocapsid into the cytoplasm [42, 44-46]. Following this, the capsid dissociates with the 
RNA, which triggers the translation of viral proteins, replication of the viral genome, and 
packaging of virions [47, 48]. Replication of the viral genomic RNA occurs within virus-induced 
membrane structures (IMS) at the surface of the endoplasmic reticulum (ER) [49], and is 
mediated in part by the NS5 protein, which has both RNA-dependent RNA polymerase (RdRP) 
[50, 51] and methyltransferase [52] activity. The organelle of origin for IMS’s varies between 
flaviviruses; the IMS for WNV appears to be derived from the ER [53, 49], with reorganization of 
the membrane being mediated by NS2A, NS2B, NS4A, and NS4B [49, 54]. Using the genomic 
RNA as a template, an antisense strand is synthesized by RdRP activity of NS5, which is then 
used as the template to produce positive-strand genomic RNAs. Immature virions are formed in 
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the lumen of the ER [55], and derive their lipid-bilayer envelope by budding through this 
organelle [56]. Mature virions emerge from the trans-Golgi network, wherein furin-mediated 
cleavage of prM into the pr peptide and M protein is necessary to produce infectious particles 
[57, 58]. Mature virions exit the cell via exocytosis [39]. 
 
WNV and Flavivirus Evolution 
Theories regarding flavivirus evolution must take into account the following 
considerations: (1) their degree of genetic relatedness, (2) the natural ecology of the viruses 
(i.e. vectors, if any, and vertebrate hosts), and (3) their geographic distribution [59]. One theory 
of vector-borne flavivirus evolution is that they arose from non-vectored ancestors, some of 
which eventually adapted to arthropod hosts [60]. Flaviviruses can be divided into three main 
categories, determined both by their phylogenetic relationships to one another as well as their 
ecological niches: those vectored by mosquitoes, those vectored by ticks, and those with no 
known vectors [61]. Genetic and antigenic relatedness between flaviviruses strongly correlates 
with their vector preference (i.e. mosquito or tick-borne) [62, 63]. Some interesting 
observations can be made when attempting to classify flaviviruses. Mosquito-borne flaviviruses 
fall into two distinct subgroups: those which have been primarily isolated from Aedes sp. 
mosquitoes, and those that have primarily been isolated from Culex sp. mosquitoes, with the 
Aedes subgroup containing two paraphyletic groups (one with YFV and the other with DENV) 
comprising 16 species, and the Culex group comprising 21 species (as of 2007) [59]. 
Interestingly, none of the viruses isolated primarily from Aedes have an avian cycle, and none of 
the viruses isolated from Culex involve a primate cycle [59]; this is likely due to the feeding 
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preferences inherent to each genus. Additionally, the primary disease manifestation in humans 
of viruses isolated in the Aedes group is hemorrhagic fever, while the diseases caused by viruses 
in the Culex group are primarily encephalitides [64]. Among the tick-borne flaviviruses, two 
groups exist: those associated with seabirds, and those associated with mammals (the TBEV 
complex) [65]. 
WNV belongs to the JEV complex within the genus Flavivirus and the family Flavivirdae, 
based on its antigenic similarity to other viruses in this complex [61]. There are five distinct 
lineages (some sources state as many as eight, including putative lineages [66]) of WNV, with 
Lineage I and II being the predominant lineages most isolates fall into. Lineage I has the largest 
geographic distribution, and is divided into several clades: clade 1a includes the pathogenic 
strain introduced into North America in 1999 (WNVNY99), and is most associated with causing 
neuroinvasive disease, clade 1b includes Kunjin virus (KUNV), a mildly pathogenic strain 
endemic to Australia [67-70], and clade 1c includes isolates from India [71]. Lineage II was 
believed to be isolated to sub-Saharan Africa, but since 2004 has been responsible for 
outbreaks in Europe, specifically in Hungary, Greece, and Spain [72-74] , and now appears to be 
established in Europe [75]. Lineages III, IV, and V are mostly restricted to Eastern Europe (III and 
IV), and India (V) [76]. Interestingly, Koutango virus (KOUV), a flavivirus initially classified as a 
separate species [77], but later shown to be a WNV variant [78, 70], has primarily been isolated 
from rodents and ticks, peculiar hosts for WNV [66]. 
Like all RNA viruses, WNV is thought to exist in nature as a quasispecies, or a collection 
of diverse genotypes diverged from a common ancestral genotype within a single infected host 
(or cell) [79, 80]. RNA viruses replicate with extremely high mutation rates [81], owing at least 
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in part to the lack of proof-reading activity of most viral RdRPs, resulting in relatively low-
fidelity replication (estimated error rate for many viral RdRPs is a single misincorporated base 
for every 104-106 nucleotides [82]; for flaviviruses this would translate to ~1 mutation per 
genome per replication event). High mutation rates may present a problem to viruses as excess 
mutations could potentially lead to population extinction [81, 83-85], since most mutations 
negatively impact viral fitness, as seen in a study with vesicular stomatitis virus (VSV, 
Rhabdoviridae) [86]. However, high mutation rates could be expected to benefit a large 
population, even if they may be detrimental on individuals [87], with the low fidelity of the viral 
RdRP allowing for rapid mutation and adaptation to new or changing environments. In support 
of this, studies with a CHIKV mutant expressing a high-fidelity RdRP have shown the mutant 
virus exhibited lower infection and dissemination rates in Ae. aegypti mosquitoes compared to 
the wild-type virus [88]. Thus, it becomes clear that RNA viruses have to find a balance between 
mutational robustness and replicative fitness. One mechanism for this may be epistatic 
interaction, where the combined effect of multiple mutations affects fitness differently than 
any individual mutation may be expected to on its own [81]. Indeed, this has been shown to be 
the case in the La Réunion island strain of CHIKV [89]. 
 
Global Importance of Flaviviruses 
As a group, arboviruses have a global distribution, being found on all continents except 
Antarctica, but many species are endemic to tropical or subtropical regions which provide for 
perennial transmission cycles through cold-blooded arthropod vectors [1]. Members of the 
genus Flavivirus are predominantly mosquito-borne, and those which cause human disease are 
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primarily encephalitic (JEV, WNV, SLEV, TBEV) or hemorrhagic fever viruses (DENV, YFV). 
Flaviviruses such as DENV and YFV have probably been afflicting humans since pre-history, but 
it has only been relatively recently that that the variety and severity of the diseases they cause 
has been appreciated. While vaccines exist for flaviviruses like YFV and JEV, sporadic outbreaks 
of these viruses still occur, often with significant mortality rates, with YFV-infection killing 
roughly 30,000 people annually [90-94]. The global burden of DENV alone is estimated to be in 
the hundreds of millions of infections per year, and recent years have seen the expansion of 
flaviviruses such as WNV into new territories. Since its introduction into the United States in 
1999, WNV has caused more than 16,000 cases of neuroinvasive disease and more than 1,500 
deaths, as of 2012 [95]. 
Tick-borne flaviviruses less commonly cause human disease, however there are several 
viruses that can cause sporadic outbreaks resulting in severe clinical manifestations. By far the 
most prevalent agents of human disease in this group are the TBEV serocomplex of viruses. 
Several thousand infections by TBE viruses are reported each year, with some outbreaks 
exhibiting case fatality rates as high as 50% [65].  
 
West Nile Virus Epidemiology and Ecology 
WNV was first isolated from the blood of a woman exhibiting febrile illness in the West 
Nile district of northern Uganda in 1937 [96]. During the next thirty years, large outbreaks of 
febrile illness caused by WNV (though few cases of neuroinvasive disease) were reported in 
Israel and South Africa [97], along with the first epidemic of WNV neuroinvasive disease in 
Europe [98]. No significant outbreaks were reported from the years 1975-1993, however from 
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1994-2000 there were numerous large epidemics resulting in meningoencephalitis 
(inflammation of the meninges, brain, or both; henceforth collectively referred to as 
encephalitis) in North Africa, Europe, North America, and the Middle East [97], including an 
outbreak in Romania in 1996 that resulted in nearly 400 cases of neuroinvasive disease and at 
least 17 deaths [99]. In 1999, an outbreak of viral encephalitis occurred in New York City, New 
York, U.S.A., [100] which preliminary analysis determined to be caused by a KUNV/WNV-like 
flavivirus [101], later shown to be a strain of WNV nearly identical to that of an isolate from a 
dead goose in Israel in 1998 [68]. WNVNY99 rapidly expanded its range in the U.S. over the next 
several years, but was displaced starting in 2001 by a new genotype (WNVWN02) [102], and was 
rendered completely extinct in favor of WNVWN02 by 2004 [103]. The reason for this 
displacement of the original genotype was found to be due to the WNVWN02 genotype exhibiting 
a dramatically shorter EIP in native mosquitoes than its rival [104], which resulted in increased 
transmission and proliferation, though a more recent study found no such difference in EIP 
between WNVNY99 and WNVWN02 [105]. WNVWN02 differs from WNVNY99 by three nucleotide (nt) 
mutations, only one of which is non-synonymous, resulting in a valine replacing an alanine in 
position 159 of the E glycoprotein (E-A159V) [102, 106], though the direct effect this mutation 
has on the virus phenotype is unknown. This situation is mirrored by the 2005 La Réunion island 
outbreak of CHIKV. The strain of CHIKV responsible for this outbreak, which resulted in >3500 
confirmed infections and an additional ~250,000 suspected infections (and unusual for CHIKV 
infections, several hundred fatalities [107]) and facilitated the spread of the virus to other 
islands and eventually mainland Europe, was found to have a single nucleotide substitution 
resulting in an alanine to valine at position 229 of the E1 envelope glycoprotein (E1-A229V) 
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[108]. Subsequent studies demonstrated that this mutation, as well as others subsequently 
found in later isolates, conferred a fitness advantage to the virus in the Asian tiger mosquito 
(Ae. albopictus), a species it was not normally vectored by [109, 89, 110, 111], and an invasive 
species that can occur in the absence of (or compete with or even replace in cases of sympatry 
[112-118]) Ae. aegypti, a previously established vector of CHIKV. This adaptive plasticity of 
arboviruses to new environments and potentially new vectors/hosts demonstrates that given 
competent arthropod vectors, a pool of amplifying vertebrate hosts, and a mechanism for 
overwintering (if necessary), arboviruses can spread with relatively little resistance [119].  
In nature, WNV persists in an enzootic cycle between ornithophilic vector mosquitoes 
and birds, primarily of the order Passeriformes (“perching birds”). At least 65 species of 
mosquitos in the U.S. , primarily of the genus Culex [120-123], have been found to be infected 
with the virus [95]. The ability of a species, population, or individual within a population to 
successfully transmit a given pathogen is known as vector competence, and is influenced by 
both intrinsic (i.e. genetics) and extrinsic factors (i.e. environment) [124], and can vary 
dramatically between species [121-123, 125-129]. Besides mosquitoes, both ixodid (hard) and 
argasid (soft) tick species have been found to be naturally infected with West Nile virus [130-
133], sometimes with infection rates as high as 11.7% [131].  Ticks have been proposed to serve 
as potential reservoirs for the virus during bird migration-mediated transfer of the virus 
between geographical locations [134], and ticks have experimentally been shown to be capable 
of transmitting the virus [135, 136]; however, the importance of ticks in the maintenance and 
transmission of WNV in nature remains unknown.  
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Susceptibility to WNV infection varies in birds, with at least 326 species of birds being 
susceptible to infection [95]. Passeriformes, Charadriiformes (shorebirds, gulls and auks), and 
domestic geese (order Anseriformes) exhibit the highest susceptibility to infection, severe 
disease, and mortality [137-140], with Psittaciformes (parrots) and Galliformes (fowl) being the 
least susceptible to infection and disease [138]. Corvids (Corvidae; crows, ravens, etc.) in 
particular develop high viremia titers and exhibit high mortality rates, often in the absence of 
marked clinical pathology [141-143], other than behavioral changes such as lethargy a day prior 
to death [144]. Prior to the 1998 outbreak in Israel, WNV was not associated with avian 
virulence, and the observed mortality in both wild and captive birds is considered unique to the 
introduction of the virus to North America [145]. It has been shown that a single mutation in 
the NS3 helicase, resulting in a threonine to proline substitution at position 249 of the protein 
(NS3-T249P) is responsible for this dramatic shift in virulence in the WNVNY99 strain compared 
to previous isolates [146]. In addition to aves, at least 30 other species of vertebrates are 
known to become infected with WNV [147]. Reptiles such as alligators [148-152], crocodiles 
[153, 154], and snakes [155] may serve as amplification/overwintering hosts for the virus, as 
with other arboviruses [156-161]. 
Human and equine infections typically occur as spillover events, whereby they are fed 
on by infected mosquitoes either due to a lack of suitable avian prey, or simply by opportunity. 
Mammals such as humans and equines are not thought to be capable of sustaining WNV 
transmission cycles due to the inability to develop sufficient viremia titer to transmit back to 
mosquitoes (established as being 104-105 plaque forming units [PFUs]/mL of blood [137]), and 
are therefore considered to be dead-end hosts for the virus [162]. 
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Mosquito Vectors of WNV in the United States 
Mosquitoes known as competent vectors of WNV primarily belong to the genus Culex. In 
particular, the Cx. pipiens complex, which includes Cx. pipiens, Cx. quinquefasciatus, Cx. 
australicus, and Cx. globocoxitus, have world-wide distributions and exhibit varying 
competencies to WNV [124]. In the United States, the predominant vector of WNV differs 
based on geographical location. In the Northeastern U.S, Cx. pipiens  and Cx. restuans appear to 
cause the majority of infections [163, 164]. Cx. tarsalis, the species thought to be responsible 
for the westward expansion of the virus, is the predominant vector in the central and Western 
U.S. [165, 166]; the sister taxon to Cx. pipiens, Cx. quinquefasciatus is a major vector in the 
Southern U.S. [167], and Cx. nigripalpus is most responsible for WNV transmission in Florida 
stretching down to Puerto Rico [168, 169]. In addition to Culex mosquitoes, mosquitoes in the 
genera Aedes and Ochlerotatus are moderately competent in laboratory settings, and may 
serve as peripheral or bridge vectors in the avian-Culex cycle, though due to their primarily 
mammalian feeding preferences, their importance in the maintenance and transmission of the 
virus is in question [127]. 
 
WNV Pathogenesis in Mosquitoes and Mammals 
In mosquitoes, WNV (and other arboviruses) are generally thought to cause persistent, 
non-lytic infections [170, 171], though apoptotic cell death has been observed in mosquito 
midguts and salivary glands after infection with a variety of arboviruses [172-179] (discussed in 
greater depth in the “Mosquito Innate Immunity to Virus Infection” section). Since they 
ultimately require to be amplified and transmitted, and that eventual transmission is likelier 
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through a healthy vector, it would seem beneficial to arboviruses to produce primarily benign 
infections within their arthropod hosts [180]. This appears to be the case with several 
arboviruses [181-183]. However, infection by arboviruses is apparently not without cost, as 
studies have shown infected mosquitoes exhibit decreased fecundity [184, 185] and increased 
blood-feeding, which ultimately increases the likelihood of transmission, but may also increase 
the likelihood of injury or death to the mosquito by its prey [124]. Intriguingly, resistance to 
WNV infection in a highly susceptible colony of Cx. pipiens was correlated with decreased 
survivorship, indicating that mounting a robust immunological response may have deleterious 
consequences for the insect as well [180]. Taken together, the variety of studies investigating 
the cost of virus infection in vectors seem to indicate that vector/virus pairing and mode of 
transmission (horizontal or vertical) appear to strongly affect the virulence of arbovirus 
infection in mosquitoes [186]. 
After imbibing a bloodmeal containing WNV, the first site of infection in mosquitoes 
occurs in the mesenteron (midgut) epithelium, where the virus presumably enters cells through 
receptor-mediated endocytosis, as with other flaviviruses [187, 188]. Studies with DENV-2 and 
Venezuelan equine encephalitis virus (VEEV, Togaviridae) indicate that only a small number of 
cells (as low as 10-15) of the midgut epithelium are initially infected [189-191]. A secreted 
protein, mosquito galactose-specific C-type lectin (mosGCTL-1), has been shown to interact 
with the E glycoprotein of WNV and facilitates its contact with the cellular surface receptor 
mosquito protein tyrosine phosphatase-1 (mosPTP-1) [192] in both Cx. quinquefasciatus and 
Ae. aegypti mosquitoes, though whether this interaction directly results in endocytosis of the 
virion or merely functions as attachment scaffolding is unknown [193]. Several mosGCTL-1 
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paralogs (but not mosGCTL-1 itself) have recently been shown to enhance DENV-2 infection in 
Ae. aegypti as well [194]. In addition to the C-type lectins, heat-shock proteins [195, 196], 
laminin receptor [197], and prohibitin [198] have also been implicated as cellular receptors for 
DENV, though the role they may play in WNV infection is unknown. Following replication in the 
midgut, the virus can disseminate into the hemocoel of the insect, infecting and replicating 
within a variety of tissues including the muscles surrounding the alimentary tract, fat bodies, 
hemocytes, and nervous tissue, before finally invading the salivary glands, which may result in 
transmission [199]. During the course of infection, the virus encounters and must circumvent 
numerous physical and immunological barriers, i.e. the midgut infection barrier [200], the 
midgut escape barrier [201], the salivary gland infection barrier [202], and the salivary gland 
escape barrier [203], with failure to do so at any of these points eliminating the possibility of 
transmission. 
 In mammalian systems, numerous cellular receptors have been proposed to participate 
in viral binding and entry [193]. Receptors implicated to be used by various flaviviruses, 
including WNV, include the glycosaminoglycan (GAG) heparin sulfate [204-209], heat shock 
proteins [210-215], the C-type lectins DC-SIGN and L-SIGN [216-221], mannose receptor [222], 
and CLEC5A [223], laminin receptor [224], phosphatidylserine receptors TIM [225, 226] and 
TAM [225], Integrin αvβ3 [227, 228], scavenger receptor Class B type I [229], claudin-1 (a 
component of tight junctions) [230, 231], and the natural killer cell activating receptor NKp44 
[232]. Most of these studies were performed using DENV, but it is possible that a dependence 
on some or all of these receptors is shared by WNV.  
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 Keratinocytes and resident dendritic cells (DCs) are the first cells to become infected 
after a mammal is infected with WNV from percutaneous exposure through the bite of a 
mosquito, with the mosquito secreting proteins in its saliva that help facilitate infection [233]. 
Migration of infected DCs to the draining lymph nodes may aid the virus in spreading to the 
visceral organs and invasion of the central nervous system (CNS) [95], which can result in the 
most serious disease manifestations associated with WNV infection; namely aseptic meningitis 
or encephalitis. Invasion of the CNS may occur through one or more mechanisms, i.e. direct 
crossing of the blood-brain barrier (BBB), facilitated transport across the BBB by infected 
macrophages (“Trojan horse”), passage through the BBB endothelium, or retrograde axonal 
transport to the CNS via olfactory or peripheral neurons [234, 95]. Approximately 80% of 
people infected with WNV are asymptomatic, and ~20% exhibit a febrile illness. Neuroinvasive 
disease associated with WNV is rare, occurring in <1% of patients [235]. Risk factors implicated 
in the development of WNV neuroinvasive disease include advanced age, gender, alcohol 
abuse, and diabetes, among others [236-240, 95]. Additionally, individuals with the CCR5Δ32 
mutation, which confers resistance to HIV-1 infection [241, 242], are also at increased risk of 
symptomatic WNV infection [243]. 
 
WNV Vaccine Development 
 Vaccines for YFV, JEV, and TBEV have been approved for use in humans for some time 
now [244]. However, at present time, there is not an approved vaccine for use in humans for 
WNV [245], though several exist for equines [246]. The E glycoprotein is the major target of 
neutralizing antibodies, and therefore the protein has largely been the focus of vaccine 
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development [247]. There are numerous candidate human vaccines for WNV in various phases 
of research and development, utilizing a variety of strategies such as live attenuated 
viruses/chimeras, plasmid DNA, inactivated virus, E glycoprotein subunits, replicons, or virus-
like particles (VLPs) [248]. Most of these vaccines are in the preclinical stage of development, 
however two are in phase I clinical trials and a single vaccine candidate is currently in stage II 
clinical trials [248]. The latter vaccine, ChimeriVAX-WN02 (Sanofi Pasteur, France) is a chimeric 
YFV-17D virus expressing WNV prM/E genes in place of the same genes from YFV [244]. Data 
from a phase II clinical trial showed that 28 days following inoculation, seroconversion was 
achieved in >96% of subjects, and that the vaccine was highly immunogenic and safely 
tolerated by all age groups at all dosage levels [249]. A second phase II study using only subjects 
≥50 years old found that among these subjects, seroconversion rates were >92% with a single 
dose of the ChimeriVAX vaccine [250], indicating that this vaccine shows promise as a safe and 
efficacious prophylaxis against WNV. 
In addition to WNV-specific vaccines, the efficacy of existing flavivirus vaccines, such as 
for JEV or YFV, has been investigated for cross-protection against WNV [245, 251-253]. There 
has been some evidence in animal models of cross-protective immunity to WNV following 
vaccination with heterologous flaviviruses [254, 255]. In mice, only partial protection upon 
challenge with WNV was seen after vaccination with the mouse brain-derived JE-VAX (BIKEN, 
Japan) inactivated virus vaccine [256]. However, the cell culture-derived JE-ADVAX (Vaxine, 
Australia) [257], which is formulated with inactivated JEV antigen and Advax, a polysaccharide, 
plant inulin-derived adjuvant [258], showed significant protection in mice after challenge with 
WNV [245, 253]. In human studies, the results of vaccination with heterologous flavivirus 
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vaccines have been less encouraging [259, 251]. The development of an effective, safe vaccine 
for WNV has some promising prospects, but given the early stages of development for most 
potential candidates, it may be a few years before one is approved and available for use in 
humans [246]. Additionally, factors such as the low cost effectiveness of a vaccine due to the 
relatively rare incidence of disease [260], and the seasonal and relatively unpredictable nature 
of WNV infection (making the design of clinical trials problematic) [246], may further delay 
these efforts. 
 
Mosquito Innate Immune Responses to Virus Infection 
Invertebrates lack an adaptive immune system, as well as many of the effector 
molecules present in mammalian innate immune response (i.e interferon), but they possess 
sophisticated mechanisms for dealing with microbial pathogens. The following section on insect 
innate immunity was excerpted from “The Role of Innate Immunity in Conditioning Mosquito 
Susceptibility to West Nile Virus” Prasad et al Viruses 2013, 5, 3142-3170 [261], which 
attempts to focus mostly on the mosquito innate immune response to WNV infection, but 
draws heavily from published data in a variety of other invertebrate host/virus systems, and is 
included to provide a detailed overview of insect innate immune pathways and their role in 
controlling arbovirus infection. 
 
Small RNA Regulatory Pathways 
Small RNA regulatory pathways (SRRPs) are an integral component of endogenous pre- 
and post-transcriptional gene regulation. Three primary classes of small RNAs exist within 
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metazoans: micro-RNAs, (miRNAs), small-interfering RNAs (siRNAs), and PIWI-interacting RNAs 
(piRNAs), being distinguished by both the size of the small RNA product, and their biogenesis. 
Invertebrates lack type I and type III interferon (IFN) responses, which are the main innate 
immune pathways through which vertebrates respond to virus infection. Rather, in 
invertebrates, there is ample evidence highlighting the role of SRRPs in antiviral innate 
immunity. Exogenous RNA interference (exo-RNAi) via the siRNA pathway appears to be the 
primary small RNA response; however, involvement of the piRNA pathway in antiviral defense 
has recently been described in both mosquitoes and mosquito cell culture. In this section, we 




RNA interference (RNAi) was first described in plants as a mechanism for “post-
transcriptional gene silencing” [262], and later, “virus-induced gene silencing” [263] , two 
phenomena which, at the time, were seemingly unrelated. Several years after these initial 
observations, double-stranded RNA (dsRNA) was found to be the trigger for RNAi in 
Caenorhabditis elegans [264] and Drosophila melanogaster [265]. In invertebrates and plants, 
exo-RNAi is induced by cellular recognition of long dsRNAs as pathogen-associated molecular 
patterns (PAMPs), which naturally occur as viral genome replication intermediates and genomic 
RNA secondary structures in the case of RNA viruses, and as convergent transcripts in DNA 
viruses. These dsRNAs are recognized and cleaved by Dicer-2 (DCR2), a cytoplasmic RNase III 
enzyme, resulting in 19-23 base pair (bp) fragments (predominately 21 bps) termed siRNAs. 
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siRNA duplexes produced in this manner exhibit 5’ monophosphates and 3’ hydroxyls, as well as 
two-nucleotide (nt) overhangs on their 3’ termini. These siRNAs are then loaded into the 
Argonaute-2 (AGO2)-containing  RNA-induced silencing complex (RISC) through association with 
a DCR2/R2D2 heterodimer [266]. After the duplex is unwound a single-stranded RNA known as 
the guide strand remains associated with the RISC, and is 2’-O methylated by the 
methyltransferase HEN1 [267, 268], and the complementary strand, known as the passenger 
strand, is degraded. The RISC then recognizes cognate mRNA (in this case, virus genomic RNA) 
by sequence complementarity with the guide strand. Cleavage of the target occurs through the 
Slicer endonuclease activity of AGO2 [269]. Unlike miRNAs, where mismatches between the 
guide strand and target are tolerated, even a single mismatch in complementarity between an 
siRNA and its target can result in diminished or abolished silencing [270, 271]. In this way, the 
siRNA pathway acts as a highly potent antiviral pathway in controlling arbovirus infection. 
The role of the siRNA pathway in antiviral defense in arthropods has been the subject of 
intense investigation in recent years. In Drosophila, numerous studies have demonstrated that 
RNAi inhibits virus replication [272-274]. Notably, Drosophila with a null mutant DCR2 enzyme 
exhibit ~70% mortality and dramatically higher virus titers when inoculated with Sindbis virus 
(SINV, Togaviridae), as compared to wild-type controls [273]. In mosquitoes, evidence of the 
involvement of the siRNA pathway during arbovirus infection has been observed in several 
virus/arthropod pairings, including o’nyong-nyong virus (ONNV, Togaviridae) in Anopheles 
gambiae [275], Sindbis virus (SINV, Togaviridae) in Aedes aegypti [276, 277], and DENV in Ae. 
aegypti [278]. viRNAs produced in response to WNV had been detected in Drosophila S2 cells, 
but not Ae. albopictus C6/36 cells [279] due to a dysfunctional siRNA pathway [280, 281] 
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resulting from a single nucleotide deletion introducing a premature stop codon within the open 
reading frame (ORF) of DCR-2 [282]. One potential pitfall in interpreting the results of these 
studies is the utilization of non-natural virus/vector pairings and/or infection routes (i.e 
intrathoracic inoculation), with the exception of Sanchez-Vargas et al. [278]. Brackney et al. 
utilized next-generation sequencing (NGS) to profile the antiviral RNAi response to WNV in its 
natural vector, Cx. quinquefasciatus mosquitoes, following peroral infection, and found viRNAs 
produced in the midgut of mosquitoes at 7 and 14 days post-infection (dpi) [283]. viRNAs 
produced in this manner were primarily 21 nts in length (indicative of DCR2 processing), and 
were asymmetrically distributed along the entire length of the virus genome. 
Given the requirement for high target sequence complementarity in siRNAs, it comes as 
no surprise that RNAi can drive viral diversity and evolution through the generation of RNAi-
escape mutants that differ sufficiently from the master sequence. Viral escape from one or a 
few transfected siRNAs has been observed in a variety of different systems, including hepatitis 
C virus (HCV, Flaviviridae) [284], human immunodeficiency virus-1 (HIV-1, Retroviridae) [271], 
turnip mosaic virus (TuMV, Potyviridae) [285], and poliovirus (PV, Picornaviridae) [286]. Based 
on the observation that WNV population structure was more complex in mosquitoes than in 
birds [287], it was hypothesized that the mosquito RNAi pathway may serve as a potent 
selective pressure on the virus to favor generation and maintenance of rare mutants. Indeed, a 
correlation between nucleotide targeting and increased likelihood for corresponding point 
mutations has been observed [283], though it is important to note that this observation was 
associative, and does not demonstrate causation. Taken together, these studies highlight the 
role this pathway may play in mosquito innate antiviral immunity, and shed light on how it may 
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influence virus diversification and evolution. Moreover, the error rate of the virus replicase 
complex may serve in part as an evolutionary mechanism for circumventing the mosquito 
siRNA-based antiviral response through the generation of rare mutants which differ sufficiently 
from the master sequence. This is circumstantially supported by the observation that a 
chikungunya virus (CHIKV, Togaviridae) mutant expressing a high fidelity RdRP exhibited lower 
infection and dissemination titers in mosquitoes as compared to the wild-type virus [88]. 
However, it should be noted that the molecular basis for this observation was not investigated, 
and that immunological factors other than RNAi could potentially influence the fitness of a 
genetically homogeneous virus population. 
Systemic RNAi, first described in plants and worms, is the process by which the siRNA 
response spreads beyond the site of initiation into surrounding cells and tissues (see [288] for a 
review). The mechanism of spread differs between plants and animals, with short-distance 
transport of siRNAs in plants occurring through plasmodesmal junctions connecting cells, and 
long-distance transport being mediated by the vascular system. In C. elegans, spread of the 
RNAi signal is mediated by members of the SID family of transmembrane transporters [289, 
290]. Evidence suggests that this process may occur in dipterans as well, and has broad 
implications in understanding RNAi-based antiviral immunity in these systems. Studies in flies 
have revealed a systemic RNAi pathway [291, 292], and cell-to-cell spread of viRNAs produced 
in response to Semliki Forest virus (SFV, Togaviridae) infection has been demonstrated in 
mosquito cell culture [293]. In C. elegans, primary viRNAs are amplified in a target dependent 
manner by the endogenous RNA-dependent RNA polymerase (RdRP) RRF-1, which contributes 
to systemic RNAi spread and subsequent maintenance of long-term silencing [294]. Secondary 
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viRNAs produced in this manner are composed entirely of antisense polarity, and exhibit 5’ di- 
or triphosphates, making them structurally unique, and thus a distinct class of small RNA 
molecules [295, 296]. While an RdRP capable of amplifying viRNAs has not been conclusively 
identified in dipterans, a recent publication suggests that viral RNA produced during flock house 
virus (FHV, Nodaviridae) infection in Drosophila can be reverse-transcribed into viral cDNAs 
mediated by the reverse transcriptase activity of endogenous long terminal repeat (LTR)-
retrotransposons [297]. Viral cDNA produced in this manner may then be integrated into the 
host cell genome, or circularized into stable, extrachromosomal DNA which can be efficiently 
transcribed into dsRNAs that can be fed back into the siRNA pathway, leading to a primed 
immune response, and allowing for a persistent infection to develop. Additionally, viRNAs 
produced in response to FHV infection in C. elegans have been observed to be 
transgenerationally inherited from mother to offspring in successive generations [298], raising 
the intriguing possibility that similar mechanisms of amplification and non-Mendelian, 
extrachromosomal inheritance of small RNAs may exist in mosquitoes as well, though it should 
be noted that to date, there is a lack of experimental data supporting this. Given the 
aforementioned importance of the RNAi pathway in mosquito innate immunity to viral 
infection, inheritance of viRNAs might be expected to influence mosquito vector competence 
and arbovirus populations in nature. 
 
Vago 
Cross-talk between SRRPs and other innate immune pathways is an emerging feature of 
mosquito antiviral defense against arboviruses. DCR2 belongs to the same family of DExD/H-
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box helicases as the RIG-I-like receptors, which are involved in the induction of the IFN 
response in mammalian systems. Deddouche et al. reported that the secreted peptide vago is 
induced in D. melanogaster in response to Drosophila C virus (DCV, Dicistroviridae) and SINV 
infection in the fat bodies of flies, and that induction of vago was reliant on the amino terminal 
DExD/H-box domain of DCR2 [299]. Notably, infection by FHV did not induce vago expression, 
likely due to the FHV encoded viral suppressor of RNAi, B2, which binds dsRNA thereby 
interfering with downstream signaling by DCR2. While vago was shown to control virus 
infection in this study, the mechanism by which it did so was unclear. Pradakar et al. further 
explored vago’s role in antiviral immunity using cultured mosquito cells and WNV [300]. It was 
found that vago was effective in limiting WNV infection in Cx. quinquefasciatus-derived Hsu 
cells, and that induction of vago resulted in activation of Jak/STAT signaling, leading to the 
induction of the STAT-dependent virus inducible gene vir-1, thereby restricting WNV 
replication. Although the identity of the cellular receptor for vago is currently not clear, studies 
published to date suggest that components of the RNAi pathway can have diverse, 
multifunctional roles in controlling arbovirus infections in mosquitoes. 
 
PIWI-Interacting RNA Pathway 
Recent evidence suggests that a second class of small RNAs with distinct biogenesis may 
also be induced in arthropods following virus infection. The p-element induced wimpy testes 
(PIWI) class of Argonaute proteins were first discovered in 1997 by Lin et al. and shown to be 
potent regulators of spermatogenesis in Drosophila [301]. In 2006, several studies were 
published indicating that PIWI proteins interact with a unique class of small RNAs, named PIWI-
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interacting RNAs (piRNAs; the nomenclature at the time was variable, and they were also 
referred to as repeat-associated small interfering RNAs [rasiRNA], which are now considered a 
distinct subclass of piRNAs) [302-306]. piRNAs exhibit some unique features that distinguish 
them from miRNAs and siRNAs. First, piRNAs are considerably larger than most miRNAs or 
siRNAs, the latter two ranging from 20-23 nts in length, the former 24-30 nts. Secondly, piRNAs 
are produced from single stranded precursor molecules independently of Dicer processing. Like 
siRNAs, but not miRNAs, piRNAs are modified by HEN1, which results in 2’-O-methylation at the 
3’ terminus of the RNA [268, 307]. Additionally, expression of piRNAs shows tissue specificity, 
with gonadal tissue being highly enriched for this species and associated proteins. 
Endogenously transcribed and processed piRNAs have been shown to be important repressors 
of transposable elements (TEs) in these tissues. However, expression of piRNAs has been 
detected in somatic tissue as well [308, 309]. 
Biogenesis of piRNAs is proposed to occur through two pathways: the primary pathway 
and the ping-pong dependent amplification loop. In the primary pathway, piRNAs are processed 
from single-stranded precursor molecules transcribed from genomic loci (piRNA clusters). In 
flies, primary piRNAs are associated with PIWI and Aubergine (AUB) [310], and are typically 
antisense to TEs [305]. Primary piRNAs produced in this manner exhibit a strong bias for a 
uridine residue at the 5’-terminus of the transcript (U1). These primary piRNAs are then fed into 
the ping-pong dependent amplification cycle, whereby after binding to their target transcript, 
cleavage occurs 10 nts upstream from the 5’ terminus of the primary piRNA [311, 312]. Thus, 
Argonaute 3 (AGO3)-associated secondary piRNAs exhibit an adenine residue in the 10 position 
(A10). Secondary piRNAs subsequently bind complementary transcripts, resulting in cleavage at 
25 
 
the A10-U basepairing, producing piRNAs corresponding to the sequence of the initial primary 
piRNA they were derived from, thereby restarting the cycle. 
Recently, the piRNA pathway has been implicated in antiviral immunity in invertebrates. 
A possible  hypothesis is that the piRNA pathway can act in a compensatory manner, such as 
when the siRNA pathway is overburdened or suppressed. Indeed, in Drosophila, flies with a null 
mutant PIWI protein exhibited significantly higher titers of WNV in comparison to wild-type 
controls [279]. Silencing of AGO3 in An. gambiae has been shown to result in increased 
dissemination of ONNV [275], and dsRNA-knockdown of piRNA-pathway component proteins 
has been shown to result in increased titers of SFV in Ae. aegypti-derived Aag2 cells, with 
knockdown of PIWI-4 in particular showing considerable effect in this regard [313]. Additionally, 
sequencing of small RNAs in DENV2-infected Ae. albopictus C6/36 cells, which as previously 
mentioned, have a dysfunctional siRNA pathway [280-282], revealed a shift from the 
stereotypically predominant distribution of siRNAs (19-23nts, no significant strand bias) to 
products consistent with the piRNA pathway (24-30 nts, predominately positive strand, A10 
bias) [281]. Wu et al. described a population of virus-derived small RNAs in their sequencing of 
persistently-infected Drosophila ovary somatic sheet (OSS) cells that held hallmarks of piRNAs; 
specifically, being between 24-30 nts in length, exhibiting a strong (95%) strand bias, and a 
preference for a 5’ uracil (though, notably, no bias for an A10 was seen) [314]. Similarly, 24-30 nt 
small RNAs produced in response to DENV2 in Ae. aegypti mosquitoes have been found by 
deep-sequencing [315]. Interestingly, piRNA-like small RNAs sequenced in the latter study 
exhibited no preference for a 5’ uracil, and only a slight bias for an A10 residue.  
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Recently, piRNA-like small RNAs exhibiting characteristics of ping-pong dependent 
amplification have been sequenced in mosquitoes and mosquito cells after virus infection. 
Morazzani et al. found that piRNA-like small RNAs are produced in the soma (non-ovarial tissue) 
of both Ae. aegypti and Ae. albopictus after infection with CHIKV, and that, unlike endogenously 
transcribed piRNAs, dsRNA was likely the biogenic precursor for virus-derived piRNAs [282]. 
Likewise, small RNAs from Aag2 and Ae. albopictus-derived U4.4 cells  infected with SINV 
shared these same characteristics [316]. In the same study, sequencing data from C6/36 cells 
infected with La Crosse virus (LACV, Bunyaviridae) revealed ping-pong dependent signatures in 
the piRNA-like viral small RNA population. Similar results from small RNA deep-sequencing of 
virus infected invertebrate hosts has also been seen in Rift Valley fever virus (RVFV, 
Bunyaviridae) infected mosquito cells [317], as well as Schmallenberg virus (SBV, Bunyaviridae)-
infected Culicoides sonorensis-derived KC cells and Aag2 cells, and blue-tongue virus (BTV, 
Reoviridae)-infected Culicoides and mosquito cells [318] (though notably, 24-30 nt small RNAs 
sequenced from BTV-infected cells did not exhibit signatures of ping-pong dependent 
amplification). The disparity between different virus/host pairings producing piRNAs either 
possessing or lacking signatures of ping-pong dependent amplification suggests that the piRNA 
response may be differentially modulated in response to infection by diverse viruses. 
     While no studies profiling the piRNA response in a Culex mosquito/WNV pairing have been 
published, the existing data in these numerous other infection models suggest that it too may 





WNV sfRNA as a viral suppressor of RNAi (VSR) 
Most arboviruses cause persistent infections within their arthropod vectors. This has led 
to speculation as to how these viruses maintain infection in the face of a robust RNAi response. 
In addition to the evolutionary mechanisms (i.e. the viral replicase error rate) described above, 
many plant and insect-specific viruses have developed molecular mechanisms for subverting 
the host RNAi response. For example, the previously mentioned FHV encodes a protein, B2, 
which binds to dsRNA and inhibits the function of DCR2, effectively rendering the siRNA 
pathway inert [319]. Plasmid-expressed LACV NSs protein has been shown to inhibit IFN and 
RNAi in mammalian cells and mice [320, 321]. However, NSs fails to show any RNAi-suppressive 
effect in LACV-infected C6/36 cells or in NSs plasmid-transfected U4.4 cells infected with SFV 
[320]. A recent publication demonstrated that DENV NS4b functions as a VSR in human Huh7 
cells via inhibition of dsRNA processing by Dicer [322]. However, whether NS4b behaves 
similarly in mosquitoes has not been investigated, and to date, no VSR activity has been 
described for an arbovirus protein during mosquito infection. Thus, it is currently not clear how 
arboviruses establish and maintain persistent infection of arthropods. 
Recently, intriguing evidence has been presented that viral subgenomic RNAs may 
function as VSRs in some cases. All flaviviruses studied thus far produce a sub-genomic RNA 
product (sfRNA) from the 3’ UTR of the virus genome [323]. In WNV, this RNA comprises the 
last 525 nts of the virus genome. sfRNA is produced by incomplete degradation of the viral 
genome by the cellular 5’-to-3’ exoribonuclease  XRN1, which stalls on the conserved 
pseudoknot-like structures present at the 5’-terminus of the 3’ UTR, resulting in large amounts 
of sfRNA accumulating within infected cells [324, 325]. Recent evidence using fluorescent 
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reporter assays suggests that the WNV sfRNA may act as a VSR by interfering with Dicer in a 
concentration-dependent manner [326], though this type of assay alone may be prone to 
misinterpretation, and should be corroborated by genetic rescue experiments [327].  The 
mechanism through which sfRNA exerts this effect is unclear, but it is hypothesized that it acts 
as a decoy substrate for DCR2. Interestingly, sfRNA has also been shown to act in a negative 
feedback loop by suppressing XRN1 activity due to the enzyme stalling at the 3’UTR [328], 
illustrating that multiple antiviral pathways can be manipulated by this decay product. 
 
Immune Signaling Cascades 
In addition to RNAi, there are numerous other innate immune pathways responsible for 
protecting insects from pathogenic organisms. These include the Toll, Immune Deficiency (Imd) 
and the Janus kinase (Jak)/signal transducer and activator of transcription (STAT) pathways, as 
well as the phenoloxidase (PO) cascade. Early characterization of these pathways revealed that 
the Toll pathway was activated upon challenge with gram-positive bacteria and fungi whereas 
the Imd pathway is responsive to gram-negative bacteria. In each case, signal transduction 
events initiated upon recognition of PAMPs by pattern recognition receptors (PRRs) results in 
the transcription of downstream effector molecules, specifically antimicrobial peptides (AMPs). 
The specific factors responsible for Jak/STAT activation and the downstream effector molecules 
are not well characterized, but numerous gene products are transcriptionally controlled by this 
pathway. The PO cascade is integral in wound healing and melanization of pathogenic 
organisms. Activation of PO results from cuticular damage or PAMP recognition. Traditionally 
thought to confer protection against bacterial, fungal and parasitic pathogens, recent evidence 
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suggests that these pathways may also play a role in antiviral immunity. The details of these 
pathways have been extensively reviewed previously [329, 330]. 
 
Toll Pathway 
The Toll pathway was originally described in Drosophila as an evolutionarily conserved 
signaling cascade involved in the establishment of the dorso-ventral axis as well as in many 
other developmental processes [330, 331]. It has since been characterized as having a 
significant role in innate immunity to gram-positive bacteria and fungi [332, 333]. More 
recently, some studies suggest that the Toll pathway may serve an important role in antiviral 
immunity. In 2005, Zambon et al. observed a significant increase in the expression of the Toll 
regulated AMPs, Drosomycin and Metchnikowin, upon Drosophila X virus (DXV; Birnaviridae) 
challenge of Drosophila [334]. It was further shown that flies lacking a functional Toll pathway 
were significantly more susceptible to DXV challenge. Similarly, it was determined that Toll 
pathway components and AMPs were significantly up-regulated upon DENV infection of Ae. 
aegypti mosquitoes [335]. Further, suppression of Cactus (a negative regulator of Toll signaling) 
or MyD88 (a Toll signaling adapter protein) resulted in modest but significant reductions and 
accumulations of infectious DENV particles in the mosquito midguts, respectively [336]. These 
findings were confirmed by another study in which Toll pathway components were up-
regulated upon DENV infection of Ae. aegypti salivary glands [337]. In addition, a modest 
increase in Dif (a Toll inducible NF-κB transcription factor) was recognized during early stages of 
SINV infection of Ae. aegypti [338]. Together, these data suggest that the Toll pathway plays a 
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role in antiviral immunity in insects; however, others have observed conflicting results [339-
341].  
Colpitts et al. observed significant reductions in the expression levels of the Ae. aegypti 
ortholog of Drosophila Spӓtzle 5 (an upstream signaling peptide of the Toll pathway) upon Ae. 
aegypti infection with three flaviviruses; WNV, yellow fever virus (YFV, Flaviviridae) and DENV 
[339]. In addition, transcript levels of the Ae. aegypti ortholog to Drosophila Toll was reduced 
upon YFV infection. These findings challenge those previously published by Xi et al. [335]. Many 
confounding factors may account for this difference, including but not limited to experimental 
design, mosquito strains, virus strains and/ or environmental conditions. The authors of this 
study did not directly address these discrepancies, but rather suggested that viral-associated 
reductions potentially indicate an evolved mechanism by which arboviruses suppress antiviral 
pathways. However, there is currently no evidence supporting this. Using the SFV – Aedes U4.4 
cell system, Fragkoudis et al. observed a down-regulation of Toll pathway component transcript 
levels upon infection by SFV. Furthermore, prior activation of the Toll pathway did not seem to 
adversely affect SFV replication in U4.4 cells [340]. From these studies it is difficult to determine 
with confidence the contribution of the Toll pathway to antiviral immunity of insects as a 
whole. However, these findings may indicate that Toll-mediated antiviral activity is specific to 
each virus–insect pairing. With regards to WNV, little is known about the role of this pathway 
during infection of insects except for the apparent down-regulation of the Spӓtzle5-like 
cytokine during infection of Ae. aegypti mosquitoes and that none of the canonical Toll 
pathway genes and/or associated AMPs were significantly altered during WNV infection of Cx. 
quinquefasciatus [341]. Further research will be needed to fully elucidate the possible 
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contributions of Toll pathway mediated antiviral immunity during WNV infection of 
mosquitoes.   
 
Immune Deficiency (Imd) Pathway 
The Imd pathway is another immune signaling cascade of insects and bears striking 
similarities to the Tumor Necrosis Factor (TNF) pathway of mammals. It was initially described 
after the identification of a mutant Drosophila line that had significantly decreased levels of 
numerous AMPs, yet maintained normal levels of another AMP, Drosomycin [332, 342, 343]. 
These findings indicated that the expression of AMPs were controlled by two or more 
regulatory cascades. It was later determined that imd mutant flies were highly susceptible to 
infection with gram-negative bacteria yet maintain resistance to gram-positive bacteria and 
fungi [330]. Recently, the Imd pathway has been implicated in antiviral immunity in insects. The 
first indication of the potential significance of the Imd pathway during viral infections was 
observed in the Drosophila - cricket paralysis virus (CrPV; Dicistroviridae) model [344]. 
Somewhat paradoxically, the authors found that while AMPs were not up-regulated during 
infection with CrPV, suggesting that neither the Imd or Toll pathways were responsive to CrPV 
infection, mutant flies lacking components of the Imd pathway were more susceptible to viral 
infection resulting in shortened lifespan and increased viral replication. Together, these data 
suggest that Imd activation is uncoupled from AMP induction during infection with CrPV, and 
implies that induction of the Imd pathway results in transcription of several other genes with 
presently unknown roles in immunity [345]. The role of the Imd pathway in antiviral immunity is 
further supported by the observations of Avadhanula et al. and Huang et al. Using a novel SINV 
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replicon transgenic Drosophila line, the authors observed increased AMP expression as well as a 
modest but significant increase in susceptibility of Imd-deficient lines to SINV challenge [346, 
347]. Additionally, Sigma virus (SIGMAV; Rhabdoviridae) infection of Drosophila induced the 
expression of numerous Imd controlled AMPs; however, the significance of these observations 
on SIGMAV replicative fitness or fly survivorship were not assessed [348]. While there have 
been several studies implicating the role of Imd during antiviral immunity, there have been just 
as many suggesting otherwise. The induction of almost all AMPs were observed during DXV 
infection of Drosophila, yet mutant flies lacking a functional Rel (an Imd inducible transcription 
factor) were no more susceptible to DXV challenge than the controls [334]. Further, a lack of 
AMP induction was observed during DCV infection of Drosophila [299, 349]. As with the Toll 
pathway, it is difficult to discern the significance of the Imd pathway in antiviral immunity based 
on these studies. This uncertainty is further confounded by the fact that the majority of these 
viruses do not naturally infect Drosophila, with the exception of SIGMAV and DCV.  
These ambiguities in the literature also encompass mosquito–virus interactions. 
Recently, a cecropin-like peptide presumed to be under the control of the Imd signaling cascade 
was found to be significantly induced upon DENV infection of Ae. aegypti salivary glands [337]. 
Characterization of this peptide revealed that it could potently inhibit DENV and CHIKV 
replication in mosquito cell culture. However, the significance of its antiviral effect has not been 
confirmed with in vivo knock-down studies. In addition, other studies have observed either 
down-regulation or insignificant differences in the expression of Imd-controlled AMPs or 
pathway components during SFV infection of Aedes U4.4 cells or ONNV infection of An. 
gambiae [340, 350], although in the former study, decreased SFV replication in Imd and 
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Jak/STAT activated U4.4 cells was observed. The biological relevance of these findings is difficult 
to determine at this time because functional assays assessing their significance during natural 
infections of adult mosquitoes have not been performed. Studies investigating the role of Imd 
during WNV infection of mosquitoes are lacking, and it remains to be seen what if any effect 
this pathway has on shaping antiviral immunity to WNV in relevant mosquito vectors; however, 
it was demonstrated that Imd gene transcripts and/or associated AMP transcripts were 
unaltered during WNV infection of Cx. quinquefasciatus [341].  
 
Jak/STAT Pathway 
The Jak/STAT pathway is an evolutionarily conserved pathway first described for its role 
in embryonic segmentation in Drosophila [351]. Subsequently it was determined that it has an 
important role in antibacterial defense. It is composed of the three major components, the 
receptor Domeless, the Janus Kinase (Jak) Hopscotch, and the transcription factor STAT [352, 
353, 351]. Unlike the Toll and Imd pathways, a well characterized subset of inducible effector 
AMPs have not been associated with this pathway; however, a handful of inducible genes 
containing a STAT binding site in their promoters have been identified, with some of these gene 
products appearing to have antiviral effects. 
The initial findings implicating a role of Jak/STAT in antiviral immunity in insects were 
observed in the Drosophila–DCV model. By performing microarray analysis on bacterial, fungal, 
and DCV challenged flies, the authors identified a subset of gene products that were up-
regulated during DCV infection but not during fungal or bacterial challenge [349]. Upon closer 
inspection the authors identified a gene, vir-1, that contained the STAT binding site within its 
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promoter and was strongly induced during DCV and FHV challenge. Furthermore, it was 
demonstrated that Jak/STAT deficient flies were more susceptible to DCV challenge as 
determined by increased DCV replication and increased mortality. These results were 
confirmed by studies performed by Kemp et al. who also demonstrated that the Jak/STAT 
pathway was important in Drosophila antiviral immunity to CrPV [354]. Interestingly, when 
Jak/STAT deficient flies were challenged with five other evolutionarily divergent viruses, 
including SINV, DXV and FHV, the authors found no effect on the survivorship of the flies. These 
results indicate that Jak/STAT involvement in antiviral immunity may be specific to each virus–
insect pairing and not broadly applicable to all systems.  
A role for Jak/STAT involvement in mosquito immunity to arboviruses has been 
described. Specifically, components of the Jak/STAT pathway as well as Jak/STAT inducible gene 
products were found to be up-regulated upon DENV infection of Ae. aegypti mosquitoes [355, 
335]. Included in these findings were two novel Jak/STAT inducible genes termed Dengue Virus 
Restriction Factors 1 and 2 (DVRF1-2). Further, it was demonstrated that suppression of these 
two genes resulted in 2.5- and 2.2-fold increases in DENV-2 replication in mosquitoes, 
respectively [355]. In addition, a recent study demonstrated that WNV induces the expression 
of vago in Hsu cells. Subsequent silencing of vago increased WNV titers. The antiviral effect of 
vago expression was determined to arise from downstream vir-1 activation via vago-induced 
Jak/STAT signaling. Studies in mosquitoes will be needed to validate the in vivo role of vago in 
controlling arbovirus infection. As with the Toll and Imd pathways others have observed 
conflicting data on the role of Jak/STAT pathway in antiviral immunity. In these studies there 
were no indications of Jak/STAT up-regulation upon infection in four separate virus – vector 
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models (ONNV/An. gambiae, SFV/Aedes U4.4 cells, WNV-DENV-YFV/Ae. aegypti, WNV/Cx. 
quinquefasciatus) [350, 340, 339, 341]. However, as previously mentioned, activation of the 
Jak/STAT pathway prior to SFV infection resulted in reduced viral replication in U4.4 cells. From 
these studies it is difficult to accurately assess the importance of the Jak/STAT pathway in 
antiviral immunity. Future studies assessing the importance of this pathway on arboviral 
infection, dissemination and transmission rates within mosquitoes will help clarify its 
significance. In the context of WNV and mosquitoes, this holds true especially considering the 
systems utilized; however, it is difficult to determine the relevance considering that one study 
was limited to cell culture and the other in an ancillary vector. Additional research into the role 
of Jak/STAT in antiviral immunity in primary mosquito vectors is clearly required in order to fully 
understand its possible influence on mosquito antiviral responses. 
 
Phenoloxidase (PO) Cascade 
Among arthropods, the PO cascade is an evolutionarily conserved extracellular pathway 
responsible for wound healing and melanization of bacterial and parasitic pathogens [329]. This 
pathway can be induced by cuticular damage or upon recognition of PAMPs. This in turn 
activates a serine protease cascade ultimately resulting in the activation of the 
prophenoloxidase activating enzyme (PPAE). Active PPAE cleaves the prophenoloxidase 
zymogen to produce PO, which catalyzes the conversion of mono- and diphenolic substrates to 
quinones, which are then converted to melanin [329]. While direct melanization of viruses has 
not been observed, there is evidence that by-products of the pathway may have antiviral 
effects. It was demonstrated that plasma from the tobacco budworm has virucidal effects on 
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Helicoverpa zea single capsid nucleopolyhedrovirus (HzSNPV; Baculoviridae) and chemical 
inhibition of PO resulted in increased viral titers [356, 357]. It was also determined that 5,6 
dihydroxyindole, a byproduct of the PO cascade, could almost completely inactivate 
Autographa californica nucleopolyhedrovirus (AcMNPV; Baculoviridae) in vitro [358]. Similar 
antiviral activity has been observed in mosquitoes. Tamang et al. observed increased SINV titers 
in Armigeres subalbatus mosquitoes after suppression of prophenoloxidase I [359]. Such 
observations were also found during SFV infection of U4.4 cells. Specifically, recombinant SFV 
over-expressing an inhibitor of the PO cascade was able to replicate to significantly higher titers 
than the control virus. It was further determined that inhibition of the PO cascade could 
decrease the survivorship of SFV infected Ae. aegypti [360]. The authors went on to 
demonstrate that the specific effector molecules involved in the antiviral effects were the 
pathway intermediate quinones. The specific nature of their antiviral effect remains to be 
determined. Together, these studies highlight the potential role of the PO cascade in insect 
immunity to arboviruses. These are the first studies to assess the role of the PO cascade in 
antiviral immunity in mosquitoes and it will be interesting to see if this antiviral effect is 
conserved among other virus – vector pairings. Future research into the involvement PO 
cascade during WNV infection of Culex spp. mosquitoes is warranted.    
 
Cellular Processes 
In addition to RNAi and the PAMP-induced signaling cascades previously discussed, 
evidence suggests that multi-functional cellular processes can have significant effects on 
arboviruses in arthropods. Cellular processes, such as apoptosis and autophagy, are important 
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in maintaining homeostasis in multicellular organisms and integral to their development. 
Autophagy, in effect, is the recycling center of the cell. It serves an important role in removing 
damaged organelles and protein aggregates which can put undue stress on the cell, ultimately 
reducing their constituent macromolecules to basic molecular building blocks and sources of 
energy. In addition, it appears to function as an innate immune defense against numerous 
prokaryotic and eukaryotic intracellular pathogens [361, 362]. Interestingly, the role of 
autophagy during viral infections is not well defined. In some systems, autophagy functions in 
an antiviral capacity while in others it can be commandeered and utilized in a pro-viral manner 
[363]. However, to date, little is known about the role of autophagy during arboviral infections 
of arthropods with the exception of the studies discussed below, which indicate a role in 
antiviral immunity. Apoptosis is the process of programmed cell death (PCD) which plays an 
integral role in eliminating old, injured or defective cells from organisms. This process can be 
differentiated from necrosis by its ability to control the release of cellular components in 
apoptotic bodies which can be scavenged by phagocytic cells and thereby diminishing any 
potential immunologic over-reaction [364]. It has been observed that such an approach to 
stress-induced cell death could predispose viruses and their associated PAMPs to antigen 
presenting cells. Not coincidently many viruses have devised mechanisms by which to subvert 
or avoid apoptosis altogether [365]. In recent years it has become evident that apoptosis may 






Autophagy is an evolutionarily conserved pathway that serves an important role in 
maintaining cellular homeostasis and cell survival [366]. Induction of autophagy results in the 
formation of double-phospholipid membrane vesicles termed autophagosomes which 
sequester the targeted organelles and proteins. Subsequently, the autophagosomes fuse with 
lysosomes forming autolysosomes which mediate degradation of the contents [367]. During 
normal growth conditions autophagy maintains cellular homeostasis by degrading unwanted or 
damaged organelles and protein aggregates. In times of cellular stress, autophagy catabolizes 
these cellular components thereby generating a pool of energy and macromolecules that 
maintain crucial cellular functions until favorable growth conditions return [366]. In addition, it 
appears to play a significant role in antiviral immunity in invertebrates. Shelly et al. 
demonstrated that deletion of autophagy-related genes (Atg’s) increased vesicular stomatitis 
virus (VSV; Rhabdoviridae) replication and decreased Drosophila survivorship [368]. It was later 
demonstrated that pre-formed PAMPs in the context of UV-inactivated virus appear to interact 
with Toll-7 at the plasma membrane, which leads to the activation of autophagy independently 
of the canonical Toll pathway [369]. These studies were the first to examine the antiviral role of 
autophagy to an arbovirus in the context of an invertebrate host. Additional studies are 







Apoptosis is a conserved mechanism of programmed cell death in multicellular 
organisms [370] that is critical to a variety of biological processes including embryonic 
development, maintenance of homeostasis, and lysis of virus-infected cells by cytotoxic T-
lymphocyes [364]. In vertebrates, apoptosis may be induced through two known pathways: the 
extrinsic, or death-receptor pathway, and the intrinsic, or mitochondrial pathway [371], though 
in dipterans only the intrinsic pathway is known to exist [372]. 
Many viruses from diverse families encode anti-apoptotic genes, such as inhibitors of 
apoptosis (IAPs), p53-binding proteins, and bcl-2 homologs. This has led to the hypothesis that 
apoptosis functions as an innate immune pathway in response to viral infection [365]. FHV 
strongly induces apoptotic events in Drosophila DL-1 cells through depletion of the Drosophila 
inhibitor-of-apoptosis-1 (DIAP1) protein, a negative regulator of initiator caspase DRONC and 
effector caspase DrICE; however, replication of FHV is not negatively impacted by apoptosis 
[373]. Similar depletion of host cell IAPs were observed in DL-1 cells [374] and Spodoptera 
frugiperda (order Lepidoptera) SF21 cells [374, 375] infected with AcMNPV, which encodes its 
own viral IAP, p35, with depletion of IAPs in both cell lines being triggered by viral DNA 
replication [374]. However, p35-deficient mutant viruses demonstrated reduced infectivity of 
SF21 cells, and reduced infectivity and lethality in Spodoptera frugiperda larvae [376]. 
Furthermore, studies in flies infected with FHV or AcMNPV reveal that rapid induction of 
apoptosis by the upstream regulator p53 limits viral gene expression and proliferation [377], 
further highlighting the importance of apoptosis in controlling virus infection in these systems. 
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Numerous studies have investigated the role apoptosis plays in arbovirus infection 
models. Apoptosis is a natural consequence of arbovirus infection in mammalian cells, where 
cytopathic effect (CPE) is frequently seen; conversely, most arboviruses are thought to cause 
minimal cytopathology in insect cells, instead resulting in non-lytic, persistent infections [170, 
171]. However, cell death consistent with apoptosis has been observed in mosquito midgut and 
salivary gland tissues following infection with a variety of arboviruses [172, 174, 176-179, 175, 
173], including WNV. With regards to WNV, apoptosis in the midgut epithelium [177] or salivary 
glands [174, 173] of Cx. pipiens or Cx. quinquefasciatus mosquitoes was associated with a 
resistance to infection or reduced ability to transmit virus, respectively. Thus, an attractive 
hypothesis is that apoptosis functions in an antiviral capacity to arbovirus infection in 
mosquitoes, and that it may be more likely to occur in mosquitoes incapable of vectoring a 
particular virus rather than permissive hosts [378, 379]. Indeed, pro-apoptotic genes in a 
refractory strain of Ae. aegypti mosquitoes were significantly up-regulated between 24 and 48 
hours post-infection (hpi) in response to DENV2 infection as compared to a susceptible strain of 
Ae. aegypti or blood-only fed mosquitoes from the same strain [380]. In the same study, 
dsRNA-knockdown of the caspase inhibitor AeIAP1 in two susceptible strains converted the 
phenotype from susceptible to refractory, and knockdown of initiator-caspase AeDronc in the 
refractory strain resulted in increased permissiveness to DENV2 infection. The same group 
previously reported up-regulation of pro-apoptotic genes in the DENV2-susceptible strain in 
comparison to the refractory strain at 48 hpi [381], indicating that apoptotic events controlling 
virus infection may be induced acutely and rapidly limit the course of infection. However, it is 
important to note that neither of these studies directly measured apoptotic events in midgut 
41 
 
tissue after DENV2 infection, and that the methods used to measure differential gene 
expression were different between studies (qPCR and suppressive subtractive hybridization, 
respectively [380, 381]). Conversely, modulation of apoptosis by RNAi-mediated silencing of 
either apoptosis inhibitors or initiators in Ae. aegypti subsequently infected with SINV produced 
results contrary to the hypothesis that apoptosis acts in an antiviral manner to arbovirus 
infection in mosquitoes [382]. Specifically, inhibition of apoptosis led to decreased infection 
and dissemination rates, and induction of apoptosis led to greater infection and dissemination. 
The authors speculate that experimental systemic induction or inhibition of apoptosis prior to 
virus infection, in contrast to apoptosis being stimulated in individual cells in response to virus 
infection, resulting in widespread destruction of structural barriers to viral 
infection/dissemination, may account for this apparent discrepancy. In summary, the variety of 
studies in mosquitoes investigating the role of apoptosis in response to arbovirus infection 
strongly implicate the pathway as contributing to the acute antiviral response; and that either 
the presence or lack of an effective apoptotic response has important consequences for vector 




Chapter 2: Small RNA Profiling of the Anti-WNV Response in Field-Collected Culex sp. 






Vertebrates and invertebrates differ in their mechanisms for combatting microbial 
infections. Vertebrates possess both innate and adaptive immune systems; however, 
invertebrates lack an adaptive immune system entirely, as well as several important innate 
immunity antiviral effector molecules found in vertebrate systems (i.e. IFN). Most eukaryotic 
organisms possess pathways for recognizing pathogen-associated molecular markers (PAMPs). 
PAMPs are recognized by pattern recognition receptors (PRRs), which can be membrane bound, 
cytoplasmic, or secreted. Double-stranded RNA (dsRNA) is a PAMP which acts as a potent 
trigger for the RNA interference (RNAi) pathway, the major innate immune response to virus 
infection in invertebrates, including dipterans such as mosquitoes [383]. Processing through the 
RNAi pathway involves endonucleolytic digestion of dsRNA into 19-23 bp small-interfering RNA 
(siRNA) duplexes, of which a single strand, known as the guide strand, is loaded into the RISC 
and facilitates sequence-specific degradation at complementary regions of target transcripts 
(such as viral RNA). Numerous studies have investigated the role of RNAi in modulating 
arbovirus infection in mosquitoes [275, 384, 276, 278, 283, 315, 282, 279, 293, 281, 316, 317]. 
However, many questions remain to be answered regarding the extent of variation in this 
response across mosquito species and populations within species.  
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The historical and current literature clearly demonstrates that mosquito species, 
populations within species, and individuals within populations vary in their intrinsic ability to 
become infected with a pathogen, support its replication, and eventually transmit to a 
vertebrate host (i.e. in their vector competence) [121, 122, 124, 123, 125-127]. The extent to 
which mosquito innate immunity to virus infection contributes to this well documented 
variation in vector competence is poorly understood. The importance of RNAi in controlling 
virus infection in insects is evident given that (1) mosquitoes engineered either by transgenesis 
[18] or by co-infection with a recombinant heterologous virus [385-387] to express dsRNA 
against a given virus are resistant to infection, and (2) mosquitoes [388] or flies [389, 273] or 
their cells [390] that have deficiencies in the RNAi pathway may rapidly succumb to virus 
infection. On the other hand, competent mosquitoes infected by West Nile virus (WNV, 
Flaviviridae) [283] and other viruses such as dengue virus (DENV, Flaviviridae) [315], Sindbis 
virus (SINV, Togaviridae) [276], and chikungunya virus (CHIKV, Togaviridae) [282] mount robust 
RNAi-based responses that seem to have minimal impact on virus replication. Importantly, no 
published studies of mosquito RNAi have examined field-collected populations of vector 
mosquitoes. This is a critical shortcoming since these are the mosquitoes that are generally 
responsible for virus transmission in nature. 
Accordingly, we sought to investigate the extent of variation in the anti-WNV small RNA 
response in natural and colonized populations of mosquitoes. We hypothesized that mosquito 
species and populations within a species may vary quantitatively and/or qualitatively in their 
RNAi response to viral infection. Specifically, we reasoned that differences in either the 
robustness of the response, the targeting of the viral genome, and the pathways involved may 
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differentially influence mosquito vector competence and viral genetic diversity. We profiled the 
antiviral small RNA response to WNV in three primary vector species (Culex sp.), as well as 
Aedes aegypti, a species which is not believed to contribute to the maintenance or 
transmission, but which exhibits competence to WNV under laboratory conditions. Our results 
demonstrate that an anti-WNV small RNA response is largely conserved among WNV vector 
species, but that one species, Cx. quinquefasciatus, demonstrates potentially significant 
deviation from the stereotypical response that we found in other mosquitoes.  
 
Materials and Methods 
Mosquito Field Collections, Rearing and Species Identification 
Oviposition traps were baited with an infusion of rabbit food pellets fermented in water 
for 5-7 days. Traps were checked daily, and Culex egg rafts were collected in individual 50 mL 
conical tubes with water and taken back to the laboratory and allowed to hatch in individual 
larval rearing bins. Cx. quinquefasciatus mosquitoes were collected in two sites in New Mexico 
separated by ~20 miles: Albuquerque (designated as ABQ) and Bernalillo (BERN). Cx. tarsalis 
egg rafts, which were not found in oviposition traps, likely because Cx. tarsalis prefers to 
oviposit in cleaner water [391], were collected from flooded tire tracks at the Turfmaster Sod 
Farms located northeast of Fort Collins, CO (designated as FC Cx. tarsalis). Cx. pipiens egg rafts 
were collected in Fort Collins, CO (designated as FC Cx. pipiens). Larvae were raised on a diet of 
powdered Tetra fish food or a 1:1 mix of powdered Tetra food and powdered rodent chow. 
Species identification was done using both L3/L4 larval morphology and a confirmatory PCR-
based assay which differentiates multiple possible Culex species based on the interspecies 
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sequence variation in the spacer regions of ribosomal DNA (rDNA) segments [392, 393]. DNA 
was extracted from L3/L4 larvae using Wizard Genomic DNA Purification Kits (Promega, 
Madison WI) or DNeasy Blood and Tissue DNA extraction kits (Qiagen, Valencia CA). After 
confirming the species of larvae from individual egg rafts, larvae were pooled according to 
species and collection site and allowed to pupate and emerge into ice-cream cartons. Adult 
mosquitoes were kept at 26-27 ⁰C with a 16:8 light:dark cycle and 70%-80% relative humidity, 
with water and sucrose provided ad libitum. Colonized Cx. quinquefasciatus (designated here 
US-Cxq, a longstanding colony of unknown duration originating from U.S. [394]), Cx. pipiens 
(designated here as PA-2004, established in 2004 from Pennyslvania collections [394]), Cx. 
tarsalis (KR83; established in 1983 from Kern County, CA collections [395]), and Ae. aegypti 
Higgs White Eye (HWE, a white-eye mutant strain of Puerto Rico, Rexville D mosquitoes [18]) 
and Rockefeller (longstanding strain possibly originating from a Havana, Cuba colony 
established in 1881 by Carlos Finlay [396]) strain mosquitoes were raised in identical conditions. 
 
Viruses and Experimental Infections 
WNV was produced from an infectious clone based on the New York 1999 (WNVNY99) 
strain of the virus as described previously [397, 283]. Briefly, the plasmid containing the full-
length infectious cDNA clone was linearized, and then in vitro transcribed into the infectious 
viral genomic RNA. Purified viral RNA was electroporated into BHK-21 cells, with the 
electroporation parameters set to 425 V, 1200Ω resistance, 25µF capacitance, and two pulses. 
Cell supernatant was collected after cells showed obvious signs of cytopathic effect (CPE; 
usually ~3 days post-electroporation). Cellular debris was removed from the supernatant by 
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centrifugation at ~3000 g, clarified supernatant was raised to a final concentration of 20% fetal 
bovine serum (FBS), and aliquots of 0.5 mL were made and stored at -80⁰C. Virus titer was then 
quantified by plaque assay on Vero cells. Virus produced in this manner exhibits a high degree 
of genetic homogeneity [398] and is well characterized phenotypically [399]. Adult female 
mosquitoes 6-8 days post-eclosion were fed an infectious bloodmeal of defibrinated goose 
blood or sheep blood mixed 1:1 with ~2 X 108 PFU/mL of infectious clone derived WNV 
(WNVicd) and raised to a final concentration of 2mM ATP. Uninfected control mosquitoes were 
fed a 1:1 mix of defibrinated sheep blood and uninfected BHK-21 cell supernatant raised to a 
final concentration of 2mM ATP. Engorged mosquitoes were held for 7 or 14 days in a BSL-3 
insectary with the same rearing conditions described previously, after which they were cold 
anesthetized, and midguts dissected and stored in miRvana RNA isolation lysis buffer (Ambion, 
Austin TX) at -80⁰C until needed for RNA isolation. 
 
Total RNA Isolation and Small RNA Library Preparations 
Total RNA was extracted from homogenized mosquito midguts using the miRvana 
miRNA isolation kit (Ambion) as per manufacturers suggested protocol for total RNA isolation. 
Eluted RNA from individual midguts were screened for the presence of WNV genomic RNA by 1-
step RT-PCR (Qiagen) using 1971-F (5’-TTGCAAAGTTCCTATCTCGTCAG-3’) and 2928c (5’-
CCAAATCCAAAATCCTCCACTTCT-3’) primers (numbers in primer designation denote genome 
position). RNA samples positive for WNV RNA were checked for RNA quality on a 2100 
Bioanalyzer (Agilent, Santa Clara CA), and then pooled into groups of 5 midgut RNAs. Pooled 
RNAs were precipitated by adding 3.25 volumes of ice-cold EtOH, 0.1 volume 3M NaOAc (pH 
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5.5), and 1.5 µL of linear polyacrylamide (5 mg/mL) as a carrier. After holding overnight at           
-20⁰C, the pools were centrifuged at ~20,000 g, washed twice with 80% EtOH, and re-
suspended in nuclease-free water. 1 µg total RNA was used as the input for small RNA library 
preparation using either the Illumina v1.5 Small RNA Prep Kit (ABQ, BERN, and Colony WNV 
14dpi sRNA libraries) or the TruSeq Small RNA Sample Prep Kit (all others) (Illumina, San Diego 
CA) as per manufacturer’s suggested protocol. Briefly, small RNAs were preferentially 3’ and 5’ 
adapter-ligated, reverse transcribed using the Superscript II reverse transcriptase (Invitrogen, 
Carlsbad CA), and PCR amplified (and in the case of TruSeq libraries, barcoded for multiplexing). 
Small RNA libraries were size selected on 6% TBE PAGE or 2% TBE-agarose gels, and purified by 
either overnight elution of the gel slice in nuclease-free water while rocking in the case of 
PAGE, or with MinElute Gel Extraction kits (Qiagen) in the case of agarose gels. Purified small 
RNA cDNA libraries were eluted in either water (PAGE gel slices) or Qiagen EB buffer (agarose 
gel slices) and sequenced on either Illumina GAIIx (Cx. quinquefasciatus ABQ, BERN, and US-Cxq 
WNV 14dpi, Ae. aegypti Rockefeller WNV 7dpi libraries) or HiSeq 2000 instruments (all others). 
 
Assembly and Analysis of sRNA Libraries 
Sequence FASTQ files were trimmed of the 3’ adapter using FASTX Toolkit [400] and 
aligned to the WNV infectious clone reference genome using Bowtie 0.12.8 [401] and allowing 
for 0-mismatches. The -a --best --strata mode was used, which instructs Bowtie to report only 
those alignments in the best alignment stratum. SAM output files produced by Bowtie were 
used as the input for processing through SAMtools [402]. Additional analyses were conducted 
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using Microsoft Excel, Graphpad Prism 6, and viRome, an R package for the analysis of viral-
derived small interfering RNA (viRNA) sequencing data [403]. 
 
qRT-PCR 
WNV genome equivalents were determined using a Taqman qRT-PCR assay amplifying a 
70bp fragment within the WNV E gene (described in [404]). 5 µL of total RNA from individual 
mosquito midgut samples used to construct our small RNA sequencing libraries or genome 
equivalent standards were used as the template in duplicate 20 µL reactions using the iScriptTM 
1-Step RT-PCR Kit for probes (Biorad, Hercules CA) with reagent ratios as per the 
manufacturer’s suggested protocol. The following primer and probe sequences were used for 
this assay: 1160-F (5’-TCAGCGATCTCTCCACCAAAG-3’), 1229-R (5’-GGGTCAGCACGTTTGTCATTG-
3’), and 1207-Probe (5’-TGCCCGACCATGGGAGAAGCTC-3’). Reactions were run on a CFX-96TM 
real-time system (Biorad). WNV genomic equivalent standards were previously generated by 
amplifying a 2.4 kb fragment from the WNV E gene using WNV 1031-F (5’-
ATTTGGTTCTCGAAGGCGAC-3’) and WNV 3430-R (5’-TGGTGGTAAGGTGCAGCTCC-3’) primers. 
The resulting amplicon was then cloned into the pCR2.1-TOPO vector (Invitrogen, Carlsbad CA) 
downstream of the T7 promoter. The recombinant vector was linearized with KpnI, purified and 
used as template for in vitro transcription using the T7 Megascript kit (Ambion) according the 
manufacturer’s instructions. In vitro transcribed RNA was then quantified and aliquoted into 





Nucleotide targeting plots of the viral genome were generated using the pileup function 
of SAMtools. Differences in the relative proportion of viRNAs by size class (i.e 19-23nts and 24-
30nts) were determined using Tukey’s multiple comparison test. Correlational analysis between 
separate data sets was conducted using the non-parametric Spearman rank coefficient rs. 
Differences in mean rs values for each species were computed using an unpaired t-test with the 
Holm-Sidak correction for multiple comparisons. 
 
Results 
Field-collected Cx. spp. mosquitoes exhibit a stereotypical viRNA response to WNV 
Sequencing of small RNAs from field-collected Cx. quinquefasciatus mosquito midguts at 
14 days post WNV infection revealed that they exhibit a stereotypical distribution of 19-23 nt 
viRNAs, with the 21 nt population of small RNAs being the most prevalent, as previously 
reported in colonized Cx. quinquefasciatus mosquitoes (Figure 2.1) [283].  While there was no 
significant difference in the relative abundance of 19-23nt viRNAs (consistent in size with 
products of the DCR-2-dependent siRNA pathway) across the three groups, 24-30nt viRNAs 
(consistent in size with products of the DCR-2-independent PIWI-interacting [piRNA] pathway) 
were significantly different across all three groups, with the ABQ group in particular being 
highly enriched for this population of small RNAs. viRNAs of 19-23nts were asymmetrically 
distributed along the length of the virus genome, exhibiting both “hot” and “cold” spots of 
targeting (Figure 2.2). Approximately 70% of the 19-23nt viRNAs in all three groups were 
derived from the positive strand of the virus, in congruence with what has previously been 
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described for Cx. quinquefasciatus mosquitoes infected with WNV [283]. In contrast, in both the 
ABQ and BERN groups, >90% of viral derived piRNA-like small RNAs (vpiRNAs) from 24-30nts 
were derived from the positive strand, consistent with the strong strand bias exhibited by 
piRNAs [282, 316] (Figure 2.3). However, this population of small RNAs lacked signatures of 
ping-pong dependent amplification, which have been observed in alphavirus [282, 313, 316] 
and bunyavirus [316-318] infected insects or insect cells, but not flaviviruses [281, 315] or 
reoviruses [318]. In the colonized group, only roughly 70% of 24-30nts viRNAs were derived 
from the positive strand, and these comprised only slightly greater than 1% of the total 19-30 nt 
viral-derived small RNA population 
 We next expanded the study to include additional mosquito species. We collected egg 
rafts of both Cx. pipiens and Cx. tarsalis mosquitoes in Fort Collins, CO (FC) and infected 
emerged adult females with WNV per os. Additionally, we infected colonized Cx. tarsalis, Cx. 
pipiens, and Ae. aegypti mosquitoes in the same manner. Midguts were harvested from 
mosquitoes at 7 and 14 dpi, and small RNA sequencing libraries were made from pools of 5 
infected midguts per timepoint (only the 7 dpi timepoint was sequenced for the Ae. aegypti 
libraries). Distribution of viRNAs by length was similar to that seen in Cx. quinquefasciatus 
mosquitoes, and there was significant variation in the percentage of 24-30nt viRNAs amongst 
field-collected and colonized groups within the same species (Figure 2.4A and 2.4B). 
Interestingly, small RNA profiles at 7dpi from both FC Cx. pipiens and Cx. tarsalis failed to show 
a prominent peak at 21nts though by 14dpi the profiles appeared typical. Rather, these libraries 
exhibited a more or less even distribution of viRNAs from 19-30nts. Due to this, we compared 
these libraries to each other, but excluded them from all other intra- and interspecies 
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comparisons, and found a high degree of correlation (rs= 0.85, data not shown).  The 
percentage of 19-23nt and 24-30nt WNV viRNAs out of the entire 19-30nt population of small 
RNAs varied greatly amongst all of the libraries, including in the Cx. tarsalis KR83 experimental 
replicates (Table 2.1). As seen in Cx. quinquefasciatus, WNV viRNAs were asymmetrically 
distributed along the length of the viral genome in the Cx. pipiens, Cx. tarsalis, and Ae. aegypti 
data sets. The positive strand/negative strand ratio for 19-23nt products varied within and 
between species. In Cx. pipiens, 19-23nt viRNAs were between 53%-64% derived from the 
positive strand, while in Cx. tarsalis the percentage of 19-23nts derived from the positive strand 
ranged between 50%-80%, with wide variation seen even among the two KR83 experimental 
replicates. 19-23nt viRNAs in the Ae. aegypti Rockefeller and HWE libraries were 83% and 77% 
derived from the positive strand, respectively. However, as seen in Cx. quinquefasciatus, 24-
30nt reads were uniformly between 94%-99% derived from the positive strand of the virus RNA 
in all of the sequencing libraries (including the FC Cx. pipiens WNV 7dpi and FC Cx. tarsalis WNV 
7dpi libraries, which were predominately positive-strand derived for all 19-30nt reads). 
 
Intra- and interspecies comparisons of midgut anti-WNV small RNA profiles from Cx. spp. and 
Ae. aegypti mosquitoes  
We next analyzed the correlation in viral genome nucleotide targeting within and 
between species. Relative intensity of nucleotide targeting (measured as number of times a 
given nucleotide position was sequenced as part of a read in a given library) of 19-23nt viRNAs 
was highly correlated between field-collected and colonized mosquitoes of the same species 
(Figure 2.5). The strength of the correlation was considerably decreased when intra-species 
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comparisons of 24-30nt nucleotide targeting were made (Figure 2.6), showing that much of the 
intra-species conservation of the total RNAi response appears to lie within the siRNA pathway. 
 Inter-species comparisons were made for all libraries excluding the FC Cx. pipiens WNV 
7dpi and FC Cx. tarsalis WNV 7dpi libraries, and are summarized in Tables 2.2 and 2.3. Cx. 
quinquefasciatus mosquitoes had a significantly lower degree of correlation with either Cx. 
pipiens or Cx. tarsalis when comparing 19-23nt viRNAs (Figure 2.7A). Interestingly, nucleotide 
targeting intensity was highly similar between multiple comparisons of Cx. pipiens and Cx. 
tarsalis libraries, as the two species exhibited similar degrees of correlation between the 
species as they did within their species. Aedes aegypti and Cx. tarsalis libraries were also similar 
to each other, though significance could not be tested due to a lack of replicate correlations 
from those species. When comparing differences in intensity of nucleotide targeting amongst 
the 24-30nt size class, there was no significant difference in intensity of nucleotide targeting in 
24-30nt vpiRNAs between the three Cx. species when compared against Cx. quinquefasciatus, 
with even Cx. quinquefasciatus exhibiting low correlations between field-collected and 
colonized groups. There was a significant difference in the correlations between Cx. 
quinquefasciatus and Cx. tarsalis when comparing against Cx. pipiens and Cx. quinquefasciatus 
and Cx. pipiens when comparing against Cx. tarsalis (Figure 2.7B). Both Cx. pipiens and Cx. 
tarsalis showed much higher degrees of intra-species correlation in 24-30 nt nucleotide 
targeting than either Cx. quinquefasciatus or Ae. aegypti. 
 We next quantified the viral load in the midguts of the individual Cx. sp. mosquitoes 
used to construct the pools as input for small RNA libraries by qRT-PCR. We found no 
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statistically significant difference in the viral burden in midguts as measured by virus genome 
equivalent copy numbers (Figure 2.8). 
 
Detection of Culex flavivirus (CxFV)-derived viRNAs in field-collected Cx. pipiens mosquito 
midguts but not Cx. quinquefasciatus or Cx. tarsalis 
 We aligned 19-30nt small RNAs to the Culex flavivirus (CxFV, Flaviviridae) genome 
(GenBank Accession # AB262759.2) allowing for 0-mismatches. CxFV-derived viRNAs were 
found in both the FC Cx. pipiens WNV 7dpi and 14dpi libraries, but not FC Cx. tarsalis or field-
collected Cx. quinquefasciatus libraries. In both FC Cx. pipiens libraries, CxFV-derived viRNAs fit 
the stereotypical siRNA distribution pattern with a significant peak at 21nts, even though as 
previously mentioned this pattern was not observed in WNV-derived viRNAs from the FC Cx. 
pipiens WNV 7dpi library. 
 
Discussion 
 RNAi is the major innate immune pathway in mosquitoes in response to arbovirus 
infection, and in the past decade has become a major focus of research in regards to 
invertebrate innate immunity [383]. However, the degree to which antiviral small RNA 
pathways vary quantitatively or qualitatively amongst vector species of mosquitoes has not 
been investigated. Since it is more or less presumed that vector competence is linked to at least 
some degree with the mosquito innate immune response to virus infection, an understanding 
of interspecies variation in innate immune responses is therefore critical. Secondly, as far as we 
are aware, all studies to date have relied on inbred colonized lab strains of mosquitoes or 
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mosquito cell culture, which may or may not recapitulate what occurs in natural infections. A 
clear understanding of how well these laboratory systems represent what occurs in nature is 
therefore critical to extrapolating data from experimental studies to the natural world.  
Here we sequenced viral-derived small RNAs from 4 species of mosquitoes, 3 of which 
encompassed both field collected and colonized populations. We found that all species 
examined exhibit a stereotypical siRNA response to WNV, with 21nt species being produced in 
the greatest abundance, as has been described before in mosquitoes [276, 282, 283]. However, 
between intra-species populations there was significant variation the percentage of viRNAs 
made up by the 24-30nt size class. These small RNAs were predominately derived from the 
positive strand, consistent in both size and strand bias with products of the piRNA pathway, 
which has been shown to be a likely participant in antiviral defense in mosquitoes [315, 282, 
281, 316, 317, 313]. Curiously, viRNA profiles from field-collected Cx. pipiens and Cx. tarsalis at 
the 7dpi timepoint exhibited atypical size distribution profiles. Additionally, all 19-30nt viRNA 
reads from these libraries were almost entirely derived from the positive strand of the virus 
(data not shown). Mosquitoes used to create these two libraries were collected at different 
times (around one year apart), and infections, dissections, RNA extractions, and preparations of 
small RNA libraries were conducted separately. Otherwise, both groups were treated the same 
(rearing conditions, infection protocol, RNA extractions, small RNA library preparation 
protocol). However, by the 14 dpi timepoint, viRNA size distribution profiles had returned to 
what is considered stereotypical. It would seem unlikely that both of these libraries would 
exhibit these signatures due to technical error, since none of the other libraries prepared for 
this study or subsequent ones discussed later in this dissertation exhibited similar profiles. 
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Additionally, when compared against one another, 19-23nt small RNA profiles from these two 
groups were strongly correlated, comparable with the strength of correlation between these 
groups at 14dpi. Similarly, 24-30nt viRNAs from these libraries were strongly correlated, even 
more so than at the 14dpi timepoint (7dpi rs= 0.87, 14dpi rs= 0.56). These results confirm that 
natural populations of vector mosquitoes exhibit a stereotypical viRNA response to virus 
infection.  
We found a high degree of intra-species homogeneity in targeting of the DCR-2 
processed 19-23nt siRNA size class in all species. However, the strength of correlation for 24-
30nt was generally less, though in Cx. pipiens and Cx. tarsalis, not markedly. This indicates that 
much of the conservation in targeting of the viral genome within different populations of the 
same species is retained within the siRNA pathway. Strikingly, when inter-species 19-23nt 
viRNA nucleotide targeting profiles were compared, Cx. pipiens, Cx. tarsalis, and Ae. aegypti 
were more highly correlated with one another than any were with Cx. quinquefasciatus. This 
was a surprising finding, given that Cx. quinquefasciatus and Cx. pipiens are closely related 
sister taxa [124]. These differences between Cx. quinquefasciatus and Cx. pipiens did not relate 
to viral burden in the midguts as measured by qRT-PCR detection of viral genome 
equivalents.WNV has been shown to undergo population bottlenecks in Cx. pipiens [405], but 
not Cx. quinquefasciatus [406], where viral genetic diversity is maintained. Presumably, RNAi 
plays a role in defining virus population structure within the mosquito vector, though it is 
impossible to draw any correlations between this present study and the previously published 
ones. Still, the finding that Cx. quinquefasciatus and Cx. pipiens differ in their RNAi targeting of 
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the WNV genome is provacative given the existing evidence showing differences in how these 
species interact with WNV. 
Evolution of RNAi component genes has been investigated in Ae. aegypti, but not Cx. sp. 
mosquitoes. In Ae. aegypti, RNAi components including dcr-2 and ago-2 have been found to 
undergo rapid evolution in natural populations [407], and polymorphisms in dcr-2 have been 
implicated in influencing vector competence in Ae. aegypti to DENV [408]. While not 
demonstrated in this study, it is plausible that polymorphisms in intra- and inter-specific 
populations of Cx. sp. mosquitoes similarly influence mosquito susceptibility to WNV infection. 
Such polymorphisms may also account for the variation in RNAi targeting profiles seen between 
species, particularly between Cx. quinquefasciatus and other Culex species.  
In addition to the above findings, the high degree of intra-specific correlations between 
small RNA targeting profiles of colonized and field-collected mosquitoes demonstrates that the 
use of heavily inbred populations, such as those in lab colonies of mosquitoes, can still 
recapitulate the antiviral RNAi response seen in natural populations. These findings add 
confidence to reports in previous studies, which have entirely relied on the use of inbred 







Figure 2.1: Distribution of viRNAs of 19-30nts from Albuquerque, NM, Bernalillo, NM, and 
colonized Cx. quinquefasciatus midguts 14dpi with WNV. Reads mapping to the positive 
strand are presented on the upper portion of the y-axis and reads mapping to the negative 
strand on the lower portion of the y-axis. Asterisk denotes significance (p<0.05) by Tukey’s 






Figure 2.2: Distribution of 19-23nt viRNAs along the length of the viral genome. 
A) Albuquerque, NM (ABQ) B) Bernalillo, NM (BERN), C) colonized mosquitoes 
(US-Cxq). Positive strand/negative strand proportions were 0.72/0.27, 0.69/0.31, 




Figure 2.3: Distribution of 24-30nt viRNAs along the length of the viral genome. A) 
Albuquerque, NM, B) Bernalillo, NM, C) US-Cxq (Colony). Positive strand/negative 
strand proportions were 0.93/0.07, 0.97/0.03, and 0.71/.29, respectively. 
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Figure 2.4: Distribution of WNV viRNAs from 19-30nts in length. A) Field-collected (FC) and colonized Cx. pipiens midguts, B) FC 
and colonized Cx. tarsalis midguts. Two separate libraries were made and sequenced for the colony mosquitoes at 7dpi, error 
bars represent SEM. C) Two colonized strains of Ae. aegypti. The HWE library was prepared using RNA isolated from whole 
mosquitoes; the Rockefeller library was prepared from midguts. Comparisons between mean percentages of 19-23nt and 24-30nt 
populations between populations in Cx. pipiens and Cx. tarsalis excluded the field-collected 7dpi timepoint for each species since 




Figure 2.5: Intra-species comparisons of 19-23nt viRNA targeting of the WNV genome. 
Each point represents a single nucleotide position. All correlations were made using 
the non-parametric Spearman rank coefficient (rs). A) rs= 0.85, 95% CI= 0.85-0.86, 
p<0.0001, B) rs= 0.84, 95% CI= 0.84-0.85, p<0.0001, C) rs= 0.80, 95% CI= 0.79-0.80, 
p<0.0001, D) rs= 0.79, 95% CI= 0.78-0.80, p<0.0001, E) rs= 0.89, 95% CI= 0.88-0.89, 





Figure 2.6: Intra-species comparisons of 24-30nt viRNA targeting of the WNV genome. 
Each point represents a single nucleotide position. All correlations were made using 
the non-parametric Spearman rank coefficient (rs). A) rs= 0.53, 95% CI= 0.52-0.54, 
p<0.0001, B) rs= 0.18, 95% CI= 0.16-0.20, p<0.0001, C) rs= 0.17, 95% CI= 0.16-0.19, 
p<0.0001, D) rs= 0.64, 95% CI= 0.63-0.65, p<0.0001, E) rs= 0.78, 95% CI= 0.77-0.79, 






Figure 2.7: Mean rs values were calculated for both intra-species and inter-species 
comparison correlations and plotted. Error bars denote SEM. A) Mean rs values for 
19-23nt viRNA targeting profiles for all species. B) Mean rs values for 24-30nt 
targeting profiles for all species. Asterisks denote significance of p < 0.05 as 

















Figure 2.8: WNV genome equivalents in individual Cx. sp. mosquito midguts as measured by 






Total 19-30 NT Reads w/ 
Adapters (X106) 
Reads Aligning to WNV         
(%) 
ABQ Cx. quinquefasciatus 
WNV 14dpi 
1.9                    29291 (1.55) 
BERN Cx. quinquefasciatus 
WNV 14dpi 
0.84                      7250 (0.86) 
US-Cxq Cx. quinquefaciatus 
WNV 14dpi 
1.5                      7504 (0.51) 
PA-2004 Cx. pipiens WNV 7dpi 2.9                      3630 (0.12) 
PA-2004 Cx. pipiens WNV 
14dpi 
2.6                    11324 (0.43) 
FC Cx. pipiens WNV 7dpi 5.8                    22105 (0.38) 
FC Cx. pipiens WNV 14dpi 0.58                      8014 (1.38) 
KR83 Cx. tarsalis WNV 7dpi 
Rep 1 
5.3                  157453 (2.99) 
KR83 Cx. tarsalis WNV 7dpi 
Rep 2 
7.7                    62356 (0.81) 
KR83 Cx. tarsalis WNV 14dpi 1.6                    37305 (2.34) 
FC Cx. tarsalis WNV 7dpi 7.7                    92629 (1.2) 
FC Cx. tarsalis WNV 14dpi 11.1                   73686 (0.66) 
HWE Ae. aegypti WNV 7dpi  16.5                   12797 (0.08) 
Rockefeller Ae. aegypti WNV 
7dpi 
1.5                     4354 (0.29) 
 
Table 2.1: Features of sequenced small RNA libraries. 
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WNV 14dpi  
-- rs= 0.85, 95% CI= 
0.85-0.86, p<0.0001 


























rs= 0.85, 95% CI= 
0.85-0.86, p<0.0001 


























rs= 0.84, 95% CI= 
0.84-0.85, p<0.0001 
rs= 0.80, 95% CI= 
0.79-0.80, p<0.0001 





















FC Cx. pipiens 
WNV 14dpi 
rs= 0.43, 95% CI= 
0.42-0.45, p<0.0001 
rs= 0.39, 95% CI= 
0.37-0.40, p<0.0001 
rs= 0.36, 95% CI= 
0.34-0.37, p<0.0001 




































rs= 0.45, 95% CI= 
0.44-0.47, p<0.0001 
rs= 0.40, 95% CI= 
0.38-0.41, p<0.0001 


















FC Cx. tarsalis 
WNV 14dpi 
rs= 0.41, 95% CI= 
0.40-0.43, p<0.0001 
rs= 0.38, 95% CI= 
0.36-0.40, p<0.0001 












































































KR83 Cx. tarsalis 
WNV 7dpi 














KR83 Cx. tarsalis 
WNV 7dpi 














KR83 Cx. tarsalis 
WNV 14dpi 
rs= 0.49, 95% CI= 
0.47-0.50, p<0.0001 
rs= 0.43, 95% CI= 
0.41-0.44, p<0.0001 

















ND -- ND ND 







































Table 2.3: Summary of intra- and interspecies correlations of 24-30nt viRNAs. rs= Spearman r value. ND= Comparison not 
determined. 
 
Table 2.3 ABQ Cx. 
quinquefasciatus 










































WNV 14dpi  
-- rs= 0.53, 95% CI= 
0.52-0.55, 
p<0.0001 























rs= 0.53, 95% CI= 
0.52-0.55, 
p<0.0001 























rs= 0.18, 95% CI= 
0.16-0.20, 
p<0.0001 
rs= 0.17, 95% CI= 
0.16-0.19, 
p<0.0001 

















FC Cx. pipiens 
WNV 14dpi 
rs= 0.36, 95% CI= 
0.35-0.38, 
p<0.0001 
rs= 0.27, 95% CI= 
0.25-0.29, 
p<0.0001 
rs= 0.14, 95% CI= 
0.12-0.16, 
p<0.0001 














pipiens WNV 7dpi 















rs= 0.47, 95% CI= 
0.46-0.49, 
p<0.0001 
rs= 0.26, 95% CI= 
0.24-0.28, 
p<0.0001 
















FC Cx. tarsalis 
WNV 14dpi 
rs= 0.38, 95% CI= 
0.36-0.39, 
p<0.0001 
rs= 0.28, 95% CI= 
0.26-0.29, 
p<0.0001 
















KR83 Cx. tarsalis 
WNV 7dpi 








































































































KR83 Cx. tarsalis 
WNV 14dpi 
rs= 0.49, 95% CI= 
0.48-0.51, 
p<0.0001 
rs= 0.28, 95% CI= 
0.26-0.30, 
p<0.0001 
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HWE Ae. aegypti 
WNV 7dpi 













aegypti WNV 7dpi 















Chapter 3: Virus-vector pairings determine the molecular signatures of virus-derived piRNA-





The canonical antiviral RNAi pathway in mosquitoes, the exogenous small-interfering 
RNA (exo-siRNA) pathway, has been the subject of much investigation in recent years. 
However, comparatively, very little is known about the role that other small RNA pathways, 
such as the micro RNA (miRNA) pathway and PIWI-interacting RNA (piRNA) pathway, may play 
in antiviral defense in mosquitoes. Recently, several studies have provided evidence suggesting 
that the piRNA pathway or components of the pathway participate in the innate antiviral 
immune response in insect systems [314, 281, 315, 317, 282, 316, 318, 313]. Like the 
endogenous siRNA (endo-siRNA) pathway, the piRNA pathway plays a significant role in 
regulating the expression of endogenous RNA transcripts. piRNAs have been shown to be 
important repressors of transposable elements (TEs) in the germline cells of a variety of 
organisms from flies to mice [409-413]. Endogenous piRNAs are believed to originate from two 
distinct pathways. In the primary piRNA pathway, piRNAs are processed from single-stranded 
RNA precursors which are transcribed from discrete genomic loci (known as piRNA clusters). 
Primary piRNAs are typically antisense to TEs, exhibit a strong bias for a 5’-uridine residue (U1), 
and in flies, are associated with the PIWI/Aubergine protein complex [310]. Primary piRNAs are 
then fed into the second pathway, the “ping-pong dependent” amplification cycle. In this 
pathway, after binding of the target transcript, cleavage occurs ten nucleotides upstream from 
the 5’ end of the primary piRNA, resulting in secondary piRNAs with an adenine residue in the 
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10 position (A10), and are Argonaute-3 (Ago3) associated [311, 312]. Cleavage of the target 
transcript presumably occurs via the Slicer activity of Ago-3, as in flies, but not mammals [414]. 
Secondary piRNAs then bind complementary targets resulting in cleavage at the A-U base-
pairing, resulting in piRNAs identical (or very similar) to the initial primary piRNA, exhibiting a 
5’-U1 residue. In fact, this nucleotide bias is a hallmark of endogenous piRNAs in flies and 
possibly mammals, and is the basis for the ping-pong dependent amplification model [311, 
312].  
However, examination of our previous small RNA sequence data from Culex 
quinquefasciatus, Cx. pipiens, Cx. tarsalis, and Aedes aegypti mosquito midguts infected by 
West Nile virus (WNV, Flaviviridae) (Chapter 2) were not entirely consistent with this model. 
Although at both 7 and 14 days post infection (dpi) 24-30nt viRNAs from these libraries were 
predominately derived from the positive strand (>90% in all libraries), consistent with the 
strong positive-strand bias seen in previous reports of viral-derived piRNA-like small RNAs 
(vpiRNAs) [314, 317, 282, 316, 318, 313], we failed to observe signatures of ping-pong 
dependent amplification. Interestingly, this signature has been widely reported in studies of 
alphavirus [282, 316, 313] and bunyavirus infections[316, 318], but not with flaviviruses (DENV) 
[281, 315] or reoviruses [318]. Therefore, while a growing body of evidence suggests that the 
piRNA pathway plays a role in antiviral defense in insects, the biogenesis of the effector 
molecules remains somewhat obscure. Further, the variety of different virus-vector pairings 
utilized make comparing the piRNA response across these systems problematic. 
 Accordingly, we sought to determine whether modes of vpiRNA production and/or 
processing is virus family-dependent. In particular, we hypothesized that, consistent with the 
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literature [281, 315], vpiRNAs produced in response to flavivirus infection would lack signatures 
of ping-pong dependent amplification while piRNAs produced in response to alphavirus 
infection would exhibit these signatures in a single species of mosquito. Cx. tarsalis is a highly 
competent natural vector for both WNV and Western equine encephalitis virus (WEEV, 
Togaviridae) in North America, and a competent laboratory vector for Sindbis virus (SINV, 
Togaviridae). We therefore infected Cx. tarsalis mosquitoes with either a flavivirus (WNV), or 
alphaviruses (WEEV, SINV) and sequenced small RNAs at 7 and 14dpi. We also investigated 
tissue-specific small RNA profiles by sequencing both midguts and carcasses sans ovaries to 
determine whether differences seen in our previous studies and previously published ones may 
be attributed to compartmental differences in the vpiRNA response. Additionally, we compared 
24-30nt small RNA profiles from Ae. aegypti mosquitoes infected with WNV to Ae. aegypti 
infected with SINV. Our results demonstrate that vpiRNAs produced in response to 
alphaviruses, but not flaviviruses, tend to be produced in a ping-pong dependent manner. 
Moreover, it appears that the mode of vpiRNA biogenesis is a unique property of specific virus-
vector pairings. 
 
Materials and Methods 
Mosquitoes 
Lab-colonized Cx. tarsalis mosquito larvae (KR83, described in [395]) were raised on a 
diet of a 1:1 mix of powdered Tetra food and powdered rodent chow. Pupae were allowed to 
emerge into containers and adult mosquitoes were kept at 26-27 ⁰C with a 16:8 light:dark cycle 
and 70%-80% relative humidity, with water and sucrose provided ad libitum. 
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Viruses and Experimental Infections 
WNV was produced from an infectious cDNA clone based on the WNVNY99 strain of the 
virus as described elsewhere [397]. WEEV isolate Imperial 181 (WEEVImp181), an isolate that 
exhibits low virulence in mice [415] but high infections rates in Cx. tarsalis mosquitoes [416, 
417], was similarly derived from an infectious cDNA clone (WEEVImp181icd). Briefly, the plasmid 
containing the full-length infectious clone was linearized with the NotI-HF restriction enzyme 
(New England BioLabs, Ipswich MA), and then in vitro transcribed into the infectious viral 
genomic RNA using the T7 Megascript kit (Ambion, Austin TX), and 5’-capped with a 
m7G(5’)ppp(5’)A cap analog (New England BioLabs, Ipswich MA). Purified viral RNA was 
electroporated into BHK-21 cells, with the electroporation parameters set to 425 V, 1200Ω 
resistance, 25µF capacitance, and two pulses. Cell supernatant was collected after cells showed 
obvious signs of cytopathic effect (CPE; usually ~3 days post-electroporation). Cellular debris 
was removed from the supernatant by centrifugation at ~3000 g, clarified supernatant was 
raised to a final concentration of 20% fetal bovine serum (FBS), and aliquots of 0.5 mL were 
made and stored at -80⁰C. Virus titer was then quantified by plaque assay on Vero cells. 
Recombinant infectious-clone derived SINV strain MRE16 with a second introduced subgenomic 
promoter 5’ to the structural genes of the virus (5’dsMRE16icd, described in [418]) was 
provided as a kind gift by Dr. Brian Foy of Colorado State University. Adult female mosquitoes 6-
8 days post-eclosion were fed an infectious bloodmeal of defibrinated sheep blood mixed 1:1 
with ~2.5 X 106 PFU/mL of WEEVImp181icd, ~2 X 108 PFU/mL of WNVNY99icd or ~5 X 107 PFU/mL of 
infectious clone derived recombinant SINV5’dsMRE16icd and raised to a final concentration of 
2mM ATP. Engorged mosquitoes were held for 7 or 14 days in a BSL-3 insectary under the same 
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conditions described above for larvae, after which they were cold anesthetized, and midguts 
dissected and stored in miRvana RNA isolation lysis buffer (Ambion) at -80⁰C until RNA 
isolation. In separate experiments, mosquitoes infected in the same manner were cold 
anesthetized at 7 and 14dpi, and both midguts and carcasses sans ovaries separately collected 
and homogenized in miRvana RNA isolation lysis buffer. 
 
Total RNA Isolation and Small RNA Library Preparations 
Total RNA was extracted from homogenized mosquito midguts using the miRvana 
miRNA isolation kit (Ambion) as per manufacturers suggested protocol for total RNA isolation. 
Eluted RNA from individual midguts and carcasses from each infection group were screened for 
the presence of WNV genomic RNA by 1-step RT-PCR (Qiagen, Valencia CA) using 1971-F (5’-
TTGCAAAGTTCCTATCTCGTCAG-3’) and 2928c (5’-CCAAATCCAAAATCCTCCACTTCT-3’) primers, 
WEEV genomic RNA using 8495-F (5’-GTTCTGCCCGTATTGCAGACACTCA-3’) and 8848c (5’-
CTCCTGATCTTTCTCTCCACGG -3’) primers, or SINV genomic RNA using 9468-F (5’-
AAAAGTGACCAGACAAAGTGGGTC-3’) and 9901c (5’-GCGGCTACTAGGACCATCAC-3’) primers 
(numbers in primer designation denote genome position). RNA samples positive for viral RNA 
were checked for RNA quality on a 2100 Bioanalyzer (Agilent, Santa Clara CA), and then pooled 
into groups of 5 midgut RNAs by virus infection and timepoint. Pooled RNAs were precipitated 
by adding 3.25 volumes of ice-cold EtOH, 0.1 volume 3M NaOAc (pH 5.5), and 1.5 µL of linear 
polyacrylamide (5 mg/mL) as a carrier. After holding overnight at -20⁰C, the pools were 
centrifuged at ~20,000 g, washed twice with 80% EtOH, and re-suspended in nuclease-free 
water. 1 µg total RNA was used as the input for small RNA library preparation using the TruSeq 
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Small RNA Sample Prep Kit (Illumina, San Diego CA) as per manufacturer’s suggested protocol. 
Briefly, small RNAs were preferentially 3’ and 5’ adapter-ligated, reverse transcribed using the 
Superscript II reverse transcriptase (Invitrogen, Carlsbad CA), and PCR amplified, during which 
time a unique oligonucleotide barcode sequence was added to each library for multiplexing. 
Small RNA libraries were size selected on 2% TBE-agarose gels, and purified with MinElute Gel 
Extraction kits (Qiagen). Purified small RNA cDNA libraries were eluted in Qiagen EB buffer, 
validated on the 2100 Bioanalyzer, and sequenced on an Illumina HiSeq 2000 instrument. 
 
Assembly and Analysis of sRNA Libraries 
FASTQ files were trimmed of the 3’ adapter using FASTX Toolkit [400] and aligned to the 
WEEVImp181, WNVNY99, SINV5’dsMRE16 infectious clone, or species-specific transposable element 
reference genomes/sequences using Bowtie 0.12.8 [401] and allowing for 0-mismatches. The -a 
--best --strata mode was used, which instructs Bowtie to report only those alignments in the 
best alignment stratum. SAM output files produced by Bowtie were used as the input for 
processing through SAMtools [402]. Nucleotide targeting plots of the viral genome were 
generated using the pileup function of SAMtools. 5’ distance plots and small RNA sequence 
conservation bar plots were produced using viRome [403], in R [419]. Additional analyses were 
conducted using Picard [420], Microsoft Excel and Graphpad Prism 6. 
 
RT-PCR screening for PIWI-component transcripts 
10 midguts and 10 ovaries were separately dissected from adult female colonized US-
Cxq Cx. quinquefasciatus mosquitoes, pooled, and homogenized in miRVana lysis buffer 
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(Ambion). Total RNA was extracted using the miRVana miRNA isolation kit and the total RNA 
protocol. Midgut and ovary pools were screened for PIWI component transcripts using the 
primers listed in Table 3.1. Reactions without the reverse transcriptase enzyme (-RT) or RNA 
template (NTC) served as negative controls. 
 
Results 
Alphavirus infection of Cx. tarsalis results in disparate positive/negative strand targeting 
ratios in midguts and carcasses 
Cx. tarsalis mosquitoes infected with either WNV, WEEV, or SINV all exhibited 
stereotypical siRNA profiles with a predominant peak at 21 nts (Figure 1). 19-23nt viRNAs made 
up between ~50-90% ( = 60.6%, n=5), ~54-88% ( = 70.4%, n=6), and ~71-96% ( = 85.2%, n=4) 
of 19-30nt viRNAs derived from WNV, WEEV, and SINV, respectively, across both midgut and 
carcass libraries for each time point. Similarly, the percentage of 24-30nt vpiRNAs varied across 
tissue, timepoint and virus, comprising between ~11-50% ( = 39.4%, n=5), ~12-46% ( = 29.6%, 
n=6), and ~4-29% ( = 14.8, n=4) of 19-30 nt viRNAs derived from WNV, WEEV, and SINV, 
respectively. Strand bias in 19-23nt viRNAs were consistent with previous studies, averaging 
between ~57-85% originating from the positive strand across all virus infections, tissues, and 
timepoints (Figure 3.2 – 3.4). vpiRNAs sequenced from both midguts and carcass libraries from 
mosquitoes infected with WNV exhibited a strong strand bias with between 96% and nearly 
100% of these small RNAs being derived from the positive strand of the virus (Figures 3.5). 
However, vpiRNAs sequenced from WEEV- and SINV-infected midguts were only between 51-
57% and 64-70% positive-strand derived, respectively (Figures 3.6A-B and 3.7A-B). Intriguingly, 
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vpiRNAs sequenced from the carcasses in these infections were predominantly positive strand-
derived (Figures 3.6C-D and 3.7C-D), consistent with ours and others’ previous observations 
[314, 282, 316, 318]. 
 
Cx. sp. mosquitoes do not produce vpiRNAs with signatures of ping-pong dependent 
amplification after infection with WNV, WEEV, or SINV. 
We next conducted sequence analysis of 24-30nt vpiRNA populations. As we previously 
observed with Cx. quinquefasciatus, Cx. pipiens, and Ae. aegypti, vpiRNAs sequenced from Cx. 
tarsalis midguts and carcasses infected with WNV, WEEV, or SINV lacked U1 or A10 biases 
expected of products of ping-pong amplification (Figures 3.8 – 3.13). We next measured the 
positional frequency of the 5’-terminus of reads mapping to opposite strands of the virus 
genome. Products of the ping-pong dependent amplification model would be expected to have 
5’-termini separated by 10 nts. As expected from the lack of U1/A10 bias, we found no such peak 
at 10 nts in either midguts or carcasses infected with WNV, WEEV, or SINV at either time point. 
However, there was a high degree of consistency observed in the 5’-distance plots in the same 
tissues across time points, most obviously in SINV-infected carcasses (Figure 3.14 and Figure 
3.15).  
To evaluate the possibility that the lack of ping-pong dependent amplification signatures 
observed in Culex midguts was due to the lack of primary components of the piRNA pathway 
are present in the mosquito midgut, we attempted to amplify these components from tissue 
mRNAs by RT-PCR. We detected the presence of 6 PIWI-component transcripts (Ago3, Arm1, 
PIWI4, PIWI5, PIWI6, SPNE) in the midguts of un-infected mature female Cx. quinquefasciatus 
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mosquitoes by RT-PCR (Figure 3.16). In Cx. quinquefasciatus, PIWI4, PIWI5, and PIWI6 are 
annotated as orthologues to D. melanogaster Aubergine (Aub) (PIWI5, PIWI6, and PIWI7 are 
Aub orthologues in Ae. aegypti) [421]. Aub is associated with primary piRNAs being fed into the 
ping-pong dependent amplification pathway. Thus, we were able to detect the necessary 
component machinery transcripts within the midguts of Cx. quinquefasciatus. Presumably, 
these transcripts are being translated, and we reason that they are likely similarly expressed in 
the midguts of Cx. pipiens and Cx. tarsalis. 
 
Ae. aegypti mosquitoes produce ping-pong dependent vpiRNAs in response to SINV infection 
but not WNV infection 
We previously sequenced small RNAs from midguts from the Rockefeller strain of Ae. 
aegypti as well as whole HWE mosquitoes after experimental infection with WNV. A third Ae. 
aegypti library (Ubi61, a transgenic strain expressing FHV B2, a viral suppressor of RNAi [422]) 
from orally WNV-infected whole mosquitoes was also made. In all three libraries, infection with 
WNV failed to produce vpiRNAs exhibiting signatures of ping-pong dependent amplification 
(Figure 3.17), and corresponding 5’-distance plots showed no peak at 10 nts (Figure 3.15D and 
3.15E). Curiously, a 28 nt RNA sequence (5’-CTGGCTGGGACACCCGCATCACGAGAGCT-3’, 
underlined nucleotides denote longer/shorter derivations of this sequence that were also 
present in high abundance) mapping to the positive strand of WNV RNA was found in 
overwhelming abundance in all three Ae. aegypti/WNV libraries. This sequence and its 
longer/shorter derivations made up 72.7%, 76.0, and 17.6% of the total 24-30nt population in 
the HWE, Rockefeller, and Ubi61 libraries, respectively. BLAST of this sequence revealed that 
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there are no known non-WNV sequences that share significant homology with the full 28nt 
RNA, and that this sequence maps to the NS5 coding region of WNV (positions 9293-9320).  To 
determine whether the striking abundance of this sequence was masking a ping-pong 
dependent signature in the rest of the 24-30nt population, we reduced all repetitive reads to a 
single instance using the MarkDuplicates option in Picard [420]. Removing repetitive sequences 
from these datasets did not reveal latent signatures of ping-pong dependent amplification in 
the rest of the dataset. Since previous reports have described ping-pong dependent vpiRNAs in 
Ae. aegypti and Ae. albopictus mosquitoes [282] and cell culture [317, 316, 313] after infection 
with alphaviruses and bunyaviruses, we analyzed a previously unpublished Ae. aegypti dataset 
derived from whole mosquitoes 9dpi with a recombinant SINV expressing eGFP (5’dsMRE16-
eGFP). 19-23nt viRNAs made up ~53% of the total 19-30nt population, with ~54% of 19-23nt 
viRNAs being derived from the positive strand (Figure 3.18). Similar to WNV infection in Cx. 
mosquitoes, but not alphavirus infection in Cx. tarsalis midguts, 92% of 24-30nt vpiRNAs were 
positive strand derived. Of note, as observed in previous studies of Ae. spp. mosquitoes or cells 
infected with alphaviruses, 24-30nt vpiRNAs show heavy targeting at the 5’-portion of the virus 
genome and near the subgenomic promoter, with very little targeting in between. Conversely, 
vpiRNAs from WNV-infected HWE and Rockefeller mosquitoes show a much more even 
distribution along the length of the viral genome, with the notable exception of a very large 
peak at NS5 resulting from the aforementioned high abundance read mapping to that gene 
(data not shown). vpiRNAs from the Ae. aegypti/SINV data set exhibited strong biases for a U1 
and A10 on the antisense and sense strand reads, respectively (Figure 3.19). As expected, 5’-
distance overlap confirmed a peak at 10 nts, suggesting a ping-pong dependent mechanism 
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(Figure 3.14F). Since we had removed duplicate sequences from the Ae. aegypti/WNV libraries, 
we performed the same treatment to the Ae. aegypti/SINV library, to ensure that detection of 
U1/A10 biases were not dependent on the abundance of particular sequences. Even after 
removing duplicate reads, 24-30nt vpiRNAs from the Ae. aegypti library still indicated a strong 
bias for both nucleotides, confirming that the nucleotide bias is due to a preponderance of 
unique sequences exhibiting the bias as opposed to a relative few in high abundance (data not 
shown). 
 
Features of endogenous piRNAs in Cx. quinquefasciatus and Ae. aegypti mosquitoes 
We next investigated whether endogenous piRNAs in Culex and Aedes mosquitoes 
exhibit signatures of ping-pong dependent amplification. Since TEs are often the targets of 
endogenous piRNAs, we aligned our Cx. quinquefasciatus midut libraries and Ae. aegypti midgut 
and whole mosquito libraries to published TE sequences from the a recent report describing 
novel LTR-retrotransposons (LTR-rTEs) in Cx. quinquefasciatus [423] and the TEfam database of 
mosquito transposable element sequences [424] . The gypsy family LTR-rTEs selected for 
alignment against Cx. quinquefasciatus small RNA midgut libraries (CqGypsy-13 and CqGypsy-
47) universally resulted in alignments mapping antisense to the LTR-rTE, as expected for piRNAs 
(Figure 3.20). Nucleotide sequence analysis revealed that in all three Cx. quinquefasciatus 
midgut libraries, the predominant base at position 1 was a U (Figures 3.21 and 3.22). However, 
a lack of sense strand reads made it impossible to confirm ping-pong dependent amplification. 
We aligned both Rockefeller Ae. aegypti midgut libraries and HWE whole mosquito libraries to 
3 Ae. aegypti gypsy LTR-rTEs: Ty3-Gypsy-121, Ty3-Gypsy-122, and Ty3-Gypsy-123. As seen in Cx. 
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quinquefasciatus, midgut library alignments resulted in nearly universally negative strand 
alignments, with a strong U1 bias (Figures 3.23-3.26). Alignments of the HWE whole mosquito 
library were predominately antisense, but a sufficient number of reads mapping directly to the 
LTR-rTE were present that we could perform sequence analysis. In this whole mosquito library, 
antisense reads exhibited a strong U1 bias while sense reads exhibited a strong A10 bias, 
indicative of a ping-pong mechanism (Figures 3.24-3.26). However, measuring the distance 
between 5’-ends of opposite strands did not reveal a peak at 10 nt (data not shown).; this likely 
resulted from the extremely low abundance of sense strand reads relative to antisense reads. 
These results suggest that a piRNA pathway is active in both the Cx. quinquefasciatus and Ae. 
aegypti midgut epithelium. 
 
Discussion 
The piRNA pathway has relatively recently been implicated in participating in the innate 
antiviral immune response in insects. However, little is known about how this pathway actually 
functions in response to virus infection. Presumably, vpiRNAs are loaded into a cytoplasmic 
“piRISC”, which in similar fashion to the siRNA pathway targets viral RNA by sequence 
complementarity leading to degradation of the viral transcript. Here we present evidence that 
this pathway can be modulated differentially in different virus/vector pairings, and that the 
presence or lack of molecular signatures characteristic of the ping-pong dependent model for 
piRNA biogenesis is neither vector nor virus specific, i.e. certain vectors do not universally 
produce RNAs with these signatures upon arbovirus infection and certain viruses do not 
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universally elicit this response in vectors. Rather, there appears to be a complex interplay 
between the specific virus and vector that determines what types of vpiRNAs are produced. 
vpiRNAs generated during alphavirus infection of Ae. aegypti mosquitoes and mosquito 
cells show a strong bias for targeting of both the 5’- and 3’- ends of the viral genome, with very 
strong positive strand bias [282, 316, 313]. Conversely, in both the midgut and carcass of Cx. 
tarsalis mosquitoes infected with either WEEV or SINV, the distribution of targeting along the 
length of the virus genome is considerably more even, and no apparent strand bias was 
observed in midguts infected with WEEV or SINV. However, in the carcasses of these 
mosquitoes, the expected positive strand bias of vpiRNAs was maintained. This suggests that 
24-30nt viRNAs are produced in disparate ways in the midgut and the rest of the soma. It is 
worth noting that in RVFV-infection of mosquito cells, the lack of strand bias for some (but not 
all) of the 25-28nt small RNAs sequenced has been observed [317], though this varies 
depending on which segment of the viral genome is being analyzed, with some segments 
showing a strong negative strand bias (perhaps expected since RVFV has a negative-sense 
segmented genome). 
We found no evidence of ping-pong dependent signatures from 24-30nt vpiRNAs 
sequenced from either flavivirus or alphavirus infection of Cx. tarsalis mosquitoes, though 24-
30nt viRNAs are generally produced in appreciable abundance during these infections. Our 
previous sequencing of small RNAs from Cx. spp. and Ae. aegypti mosquitoes infected with 
WNV similarly showed a lack of these signatures, and this has also been observed in sequencing 
of small RNAs from DENV-infected Ae. aegypti mosquitoes and Ae. spp.-derived mosquito cells 
[281, 315]. However, the finding that alphavirus infection (in particular SINV infection) did not 
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produce molecular signatures of ping-pong dependent amplification was surprising, given that 
both the published literature as well as our data described in this manuscript indicate that 
alphavirus infection in Ae. aegypti mosquitoes and mosquito cells does elicit production of ping-
pong dependent vpiRNAs [282, 316, 313]. We addressed the issue as to whether the lack of a 
ping-pong mechanism was unique to the Cx. tarsalis midgut by sequencing carcasses sans 
ovaries; despite this, we found no evidence that this mechanism was functioning in either 
compartment. We were able to detect piRNA-component protein RNA transcripts in the 
midguts of Cx. quinquefasciatus mosquitoes, and presumably these transcripts are actively 
being translated. Additionally, our analysis of 24-30nt reads aligning to species-specific LTR-
rTE’s strongly suggest that a piRNA pathway is active and functional in the midguts of both Cx. 
quinquefasciatus and Ae. aegypti. While we did not directly test this for Cx. tarsalis, we have 
extrapolated this data to assume that the piRNA pathway functions in the midgut of these 
mosquitoes as well. 24-30nt small RNAs aligning to LTR-rTEs from midgut libraries were almost 
entirely or entirely antisense to the LTR-rTE, and had a predominant U1 bias. Alignments made 
with libraries constructed from whole Ae. aegypti mosquitoes showed a distinct antisense bias, 
with a U1 residue on the antisense strand, and an A10 bias on the positive strand, indicative of a 
ping-pong dependent mechanism. Given that these libraries were made from whole 
mosquitoes with ovaries intact, it is possible that some or most of these reads were derived 
from reproductive tissue, where piRNAs and LTR-rTEs are most abundant. However, production 
of vpiRNAs with signatures of ping-pong dependent amplification have been reported in the 




A perplexing observation in Ae. aegypti/WNV libraries was the massive over-
representation of a single 28 nt sequence, or slightly shorter/longer derivations of it, which 
accounted for a substantial proportion of the 24-30 nt reads from those libraries. In Ubi61 
mosquitoes, which express Flock house virus (FHV, Nodaviridae) B2, a viral suppressor of RNAi, 
this sequence was still present in great abundance, though as a significantly lower proportion of 
the total 24-30nt sequence than either of the two RNAi-competent Ae. aegypti libraries we 
sequenced. The sequence, which maps to the NS5 viral replicase gene, was not present in 
appreciable amounts in any of the numerous Cx. spp./WNV libraries we have sequenced for this 
and other studies, and is sometimes completely absent from those libraries. Interestingly, we 
attempted to find this sequence in a previously published C6/36/WNV small RNA dataset and 
were unable to find it either. It is unlikely that the large proportion of this sequence is due to 
sequencing bias, since it was replicated in multiple libraries sequenced on different 
instruments. 
One of the more striking observations made in our studies was the disparity between 
vpiRNAs produced in response to either WNV or SINV-infection in Ae. aegypti mosquitoes. We 
observed no signatures of ping-pong dependent amplification in our sequencing of small RNAs 
from Ae. aegypti midguts or whole mosquitoes infected with WNV, yet a previously 
unpublished small RNA dataset from Ae. aegypti whole mosquitoes infected with a 
recombinant SINV showed signatures indicative of a ping-pong dependent amplification 
mechanism. Previous studies with Ae. aegypti mosquitoes infected with another flavivirus, 
DENV-2, showed only a slight bias for an A10 residue, and no bias for a U1 residue [281, 315]. 
Similarly, Ae. aegypti-derived Aag2 cells infected with DENV fail to produce piRNAs indicative of 
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a ping-pong mechanism, as do Ae. albopictus-derived C6/36 mosquito cells, which have a 
dysfunctional siRNAi pathway due to a premature stop codon in dcr-2 [280, 281], but which 
produce products consistent in size with vpiRNAs [281, 280]. Therefore, it is apparent that the 
exogenous piRNA response in at least Ae. aegypti mosquitoes is differentially modulated upon 
infection with either flaviviruses or alphaviruses. The reasons for this are unclear. Both 
flaviviruses and alphaviruses have single-stranded, positive-sense RNA genomes; however 
alphaviruses produce a smaller 26S subgenomic transcript during replication of the full length 
42S genomic RNA [425]. However, these differences in the replication of flaviviruses and 
alphaviruses do not account for the disparity observed in vpiRNAs produced from Cx. tarsalis 
and Ae. aegypti mosquitoes in response to alphavirus infection. Thus, it appears that the 
products of the exogenous piRNA pathway in mosquitoes during arbovirus infection are 
dependent on both host and viral determinants. We have summarized our findings and those of 




Table 3.1: Primer sequences used to screen for PIWI component transcripts in Cx. quinquefasciatus. Designation next to gene name 
denotes Vectorbase ID. 
 
Target Gene Forward Primer Reverse Primer 
Ago3 (CPIJ005275) 5’-AGTACATCAACCAGCATCGAG-3’ 5-TGCAGAATTGTTTCCACGTTG-3 
Arm1 (CPIJ001245) 5-GTGAATTCCAAGCCCTAATGC-3 5-TCCAGCAACCTACCCAAATC-3 
PIWI 4  Txn 1(CPIJ012516) 5-TCAAGGTGCTCATGGAATCG-3 5GACCGTTGAGTAGAATTCCGAG-3 
PIWI 5 Txn 1 (CPIJ017382) 5- TGAAGTTGACGCTGATTGGG-3 5- ACGATGGGTAAGTTCTGCAC-3 
PIWI 6 (CPIJ017381) 5-CTACATTACCAGCATCCGACAG-3 5-TGCACTTCTCAAACAGGTCG-3 







Figure 3.1: Read length distributions for Cx. tarsalis small RNA libraries. Reads on the 
negative portion of the x-axis denote reads mapping to the negative strand of the virus. 
Error bars represent SEM in libraries with replicates. A) Cx. tarsalis/WNVNY99, B) Cx. 
tarsalis/WEEVImp181, C) Cx. tarsalis/SINV5’dsMRE16. 
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Figure 3.2: Distribution of 19-23 nt reads along the length of the WNVNY99 genome. A) Cx. tarsalis midgut WNVNY99 7dpi. 
Positive/negative strand ratio is 53.0%/47.0%. This represents one of two experimental replicates; the second had a strand ratio 
of 80.5%/19.5%. B) Cx. tarsalis midgut WNVNY99 14dp. Positive/negative strand ratio is 71.4%/28.6%. C) Cx. tarsalis carcass sans 
ovaries WNVNY99 7dpi. Positive/negative strand ratio is 80.1%/19.9%. D) Cx. tarsalis carcass sans ovaries WNVNY99 14dpi. 





Figure 3.3: Distribution of 19-23 nt reads along the length of the WEEVImp181 genome. A) Cx. tarsalis midgut WEEVImp181 7dpi. 
Positive/negative strand ratio is 55.1%/44.9%. This represents one of two experimental replicates; the second had a strand ratio 
of 51.4%/48.6%. B) Cx. tarsalis midgut WEEVImp181 14dpi. Positive/negative strand ratio is 55.5%/44.5%. This represents one of 
two experimental replicates; the second had a strand ratio of 51.8%/48.2%. C) Cx. tarsalis carcass sans ovaries WEEVImp181 7dpi. 
Positive/negative strand ratio is 75.5%/24.5%. D) Cx. tarsalis carcass sans ovaries WEEVImp181 14dpi. Positive/negative strand 




Figure 3.4: Distribution of 19-23 nt reads along the length of the SINV5’dsMRE16 genome. A) Cx. tarsalis midgut SINV5’dsMRE16 7dpi. 
Positive/negative strand ratio is 51.6%/48.4%. B) Cx. tarsalis midgut SINV5’dsMRE16 14dpi. Positive/negative strand ratio is 
53.5%/46.5%. C) Cx. tarsalis carcass sans ovaries SINV5’dsMRE16 7dpi. Positive/negative strand ratio is 64.4%/35.6%. D) Cx. tarsalis 




Figure 3.5: Distribution of 24-30 nt reads along the length of the WNVNY99 genome. A) Cx. tarsalis midgut WNVNY99 7dpi. 
Positive/negative strand ratio is 96.1%/3.9%. This represents one of two experimental replicates; the second had a strand ratio of 
98.9%/1.1%. B) Cx. tarsalis midgut WNVNY99 14dpi. Positive/negative strand ratio is 96.8%/3.2%. C) Cx. tarsalis carcass sans 
ovaries WNVNY99 7dpi. Positive/negative strand ratio is 99.4%/0.6%. D) Cx. tarsalis carcass sans ovaries WNVNY99 14dpi. 




Figure 3.6: Distribution of 24-30 nt reads along the length of the WEEVImp181 genome. A) Cx. tarsalis midgut WEEVImp181 7dpi. 
Positive/negative strand ratio is 55.7%/44.3%. This represents one of two experimental replicates; the second had a strand ratio 
of 54.2%/45.8%. B) Cx. tarsalis midgut WEEVImp181 14dpi. Positive/negative strand ratio is 57.0%/43.0%. This represents one of 
two experimental replicates; the second had a strand ratio of 51.0%/49.0%.  C) Cx. tarsalis carcass sans ovaries WEEVImp181 7dpi. 





Figure 3.7: Distribution of 24-30 nt reads along the length of the SINV5’dsMRE16 genome. A) Cx. tarsalis midgut SINV5’dsMRE16 7dpi. 
Positive/negative strand ratio is 63.9%/36.1%. B) Cx. tarsalis midgut SINV5’dsMRE16 14dpi. Positive/negative strand ratio is 
69.7%/30.3%. C) Cx. tarsalis carcass sans ovaries SINV5’dsMRE16 7dpi. Positive/negative strand ratio is 97.1%/2.9%. D) Cx. tarsalis 




Figure 3.8: Barplot showing the relative frequencies of each nucleotide in the 
24-30nt population of small RNAs from Cx. tarsalis WNVNY99-infected midguts 








Figure 3.9: Barplot showing the relative frequencies of each nucleotide in the 
24-30nt population of small RNAs from Cx. tarsalis WNVNY99-infected midguts 








Figure 3.10: Barplot showing the relative frequencies of each nucleotide in 
the 24-30nt population of small RNAs from Cx. tarsalis WEEVImp181-infected 








Figure 3.11: Barplot showing the relative frequencies of each nucleotide in 
the 24-30nt population of small RNAs from Cx. tarsalis WEEVImp181-infected 








Figure 3.12: Barplot showing the relative frequencies of each nucleotide in 
the 24-30nt population of small RNAs from Cx. tarsalis SINV5’dsMRE16-infected 








Figure 3.13: Barplot showing the relative frequencies of each nucleotide in 
the 24-30nt population of small RNAs from Cx. tarsalis SINV5’dsMRE16-infected 













Figure 3.14: 5’-distance plots of 24-30nt reads mapping to opposite strands of 
the virus genome showing the relative frequency of finding the 5’-end of a 
complimentary small RNA. The dashed line at 9 nt indicates the position at which 
a peak would indicate a distance of 10 nt (the first nucleotide is at position 0), 
indicative of a ping-pong mechanism. A) Cx. tarsalis WNVNY99-infected midguts, B) 





Figure 3.15: 5’-distance plots of 24-30nt reads mapping to opposite strands of the 
virus genome showing the relative frequency of finding the 5’-end of a 
complimentary small RNA. The dashed line at 9 nt indicates the position at which a 
peak would indicate a distance of 10 nt (the first nucleotide is at position 0), 
indicative of a ping-pong mechanism. A) Cx. tarsalis WNVNY99-infected carcasses, B) 
Cx. tarsalis WEEVImp181-infected carcasses, C) Cx. tarsalis SINV5’dsMRE16-infected 
carcasses, D) HWE Ae. aegypti WNVNY99-infected whole mosquitoes 7dpi, E) Ubi61 
Ae. aegypti WNVNY99-infected whole mosquitoes 7dpi, F) Ae. aegypti SINV5’dsMRE16-





Figure 3.16: RT-PCR detection of 6 PIWI-component protein RNA transcripts in the midgut 
(M) and ovaries (O) of un-infected adult female Cx. quinquefasciatus mosquitoes. 
Reproductive tissue such as the ovaries are expected to be rich in piRNAs and component 
proteins, and were used as a positive control to compare against midgut detection. 
Reactions without reverse transcriptase (-RT) were used to exclude signal being a result of 








Figure 3.17: Barplot showing the relative frequencies of each nucleotide in 
the 24-30nt population of small RNAs from WNVNY99-infected Ae. aegypti 
mosquitoes. (A) Rockefeller strain midguts 7dpi (B) HWE strain whole 












Figure 3.18: Distribution of reads along the length of the SINV5’dsMRE16-eGFP genome. A) Ae. 
aegypti whole mosquitoes SINV5’dsMRE16 9dpi 19-23 nt reads. Positive/negative strand ratio 
is 53.9%/46.1%. B) Ae. aegypti midgut SINV5’dsMRE16-eGFP 9dpi 24-30 nt reads. 








Figure 3.19: Barplot showing the relative frequencies of each nucleotide in the 24-30nt 






Figure 3.20: Read length distribution of reads aligning to LTR-rTE in Cx. quinquefasciatus 









Figure 3.21: Barplot showing the relative frequencies of each nucleotide in 
24-30 nt small RNAs mapping to the CqGypsy-13 LTR-rTE. A) ABQ Cx. 
quinquefasciatus WNV 14dpi midgut, B) BERN Cx. quinquefasciatus WNV 









Figure 3.22: Barplot showing the relative frequencies of each nucleotide in 
24-30 nt small RNAs mapping to the CqGypsy-47 LTR-rTE. A) ABQ Cx. 
quinquefasciatus WNV 14dpi midgut, B) BERN Cx. quinquefasciatus WNV 











Figure 3.23: Read length distributions of reads aligning to LTR-rTE’s in Ae. aegypti 
midguts (Rockefeller) and whole mosquitoes (HWE). A) Reads aligning to Tyr3-
Gypsy121, B) Reads aligning to Tyr3-Gypsy122, C) Reads aligning to Tyr3-Gypsy123. 









Figure 3.24: Barplot showing the relative frequencies of each nucleotide 
in 24-30 nt small RNAs mapping to the Tyr3-Gypsy121 LTR-rTE in Ae. 
aegypti. A) Rockefeller Ae. aegypti WNV 7dpi midgut reads mapping to 
antisense strand B) HWE Ae. aegypti WNV 7dpi whole mosquito reads 










Figure 3.25: Barplot showing the relative frequencies of each nucleotide 
in 24-30 nt small RNAs mapping to the Tyr3-Gypsy122 LTR-rTE in Ae. 
aegypti. A) Rockefeller Ae. aegypti WNV 7dpi midgut reads mapping to 
antisense strand B) HWE Ae. aegypti WNV 7dpi whole mosquito reads 










Figure 3.26: Barplot showing the relative frequencies of each nucleotide 
in 24-30 nt small RNAs mapping to the Tyr3-Gypsy123 LTR-rTE in Ae. 
aegypti. A) Rockefeller Ae. aegypti WNV 7dpi midgut reads mapping to 
antisense strand B) HWE Ae. aegypti WNV 7dpi whole mosquito reads 




 WNV DENV WEEV SINV CHIKV SFV LACV RVFV SBV BTV 
Cx. 
quinquefasciatus 
No1 - - - - - - - - - 
Cx. pipiens No1 - - - - - - - - - 
Cx. tarsalis No1 - No1 No1 - - - - - - 
Ae. aegypti No1 No3,8 - Yes1 Yes5 - - - - - 
Ae. albopictus - - - - Yes5 - - - - - 
C6/36 No2 No8 - Yes4 Yes5 - Yes4 Yes7 - - 
U4.4 - - - Yes4 Yes5 Yes6 - Yes7 - - 
Aag2 - No8 - - - Yes6 - Yes7 Yes9 No9 
 
  
Table 3.2: Summary of studies profiling the small RNA response in mosquitoes and mosquito 
cells to different virus infections. “Yes” indicates a ping-pong dependent piRNA response 
was found, “No” indicates signatures of a ping-pong dependent mechanism were not found 
or that incomplete features were found (such as the bias for one nucleotide being present 
but not the other). 1 This study, 2 Brackney et al 2010 PLoS Neglected Tropical Diseases, 3 
Hess et al 2011 BMC Microbiology, 4 Vodovar et al 2012 PLoS ONE, 5 Morazzani et al 2012 
PLoS Pathogens, 6 Schnettler et al 2013 Journal of General Virology, 7 Léger et al 2013 Journal 
of Virology, 8 Scott et al 2010 PLoS Neglected Tropical Diseases, 9 Schnettler et al 2012 
Journal of Virology. Abbreviations: WNV=West Nile virus, DENV= dengue virus, WEEV= 
Western equine encephalitis virus, SINV= Sindbis virus, CHIKV= chikungunya virus, SFV= 
Semliki Forest virus, LACV= La Crosse virus, RVFV= Rift Valley fever virus, SBV= 
Schmallenberg virus, BTV= blue-tongue virus. 
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Chapter 4: Small RNA Response of Culex quinquefasciatus to West Nile Virus Infection: 





 Arboviruses perpetuate in nature through alternating replication in two hosts: the 
invertebrate arthropod host (vector), and the vertebrate host (avian, mammalian, reptilian). 
Thus, arboviruses must overcome distinct physical and immunological challenges within these 
disparate hosts or become extinct. It has long been appreciated that different mosquito 
species, populations within a single species, and individuals within populations vary 
considerably in their ability to transmit pathogens. The likelihood that a given arthropod is 
susceptible to infection by a given agent, can support its replication within and dissemination 
from the midgut (first site of infection) and secondary tissues, and eventually release the agent 
into saliva is known as “vector competence.” Vector competence is influenced by both intrinsic 
(e.g. genetics) and extrinsic (diet, temperature) factors [124]. Barriers to infection, 
dissemination, and transmission, such as the midgut infection barrier (MIB) [200], midgut 
escape barrier (MEB) [201], salivary gland infection barrier (SIB) [202], and salivary gland escape 
barrier (SEB) [203] play important roles in defining the infection phenotype and thus the vector 
competence of the mosquito. Vector competence is a component of vectorial capacity (VC), a 
calculation of a mosquito population’s capacity to transmit a given pathogen to a naïve 
population [124]. 
 The impact of RNA interference (RNAi) on arbovirus transmission in nature remains the 
subject of intensive investigation. The exogenous small-interfering RNA (exo-siRNA) pathway is 
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the main innate immune pathway responsible for controlling virus infection in mosquitoes 
[383]. Although it is clear that the exo-siRNA pathway can protect mosquitoes from lethal virus 
infection [388], and that mosquitoes engineered to express short viral RNA sequences either by 
transgenesis or co-infection with a heterologous recombinant virus are resistant to infection 
and/or incapable of transmitting virus [387, 18, 20, 385, 386], the role of RNAi in determining 
vector competence under natural conditions is unclear. A primary component of the siRNA 
pathway, Dcr-2, has been shown to be undergoing rapid diversifying evolution in Aedes aegypti 
[407], and polymorphisms in this gene correlate with differences in vector competence to DENV 
among populations of this species [407, 408]. However, it is unknown what phenotypic effect 
polymorphisms in Dcr-2 may impart on the activity of the enzyme, nor how this affects the 
functionality and/or efficacy of the siRNA pathway. In addition, little is known about how the 
antiviral RNAi response in mosquitoes changes temporally during arbovirus infection, and how 
early this response is induced after imbibing an infectious bloodmeal. In Ae. aegypti, viRNAs 
derived from DENV-2 have been observed as early as 2 dpi, and the profile of the total viral-
derived small RNA population (i.e. genome targeting, strand bias, proportion of small RNA size 
classes) changes over time from 2 dpi to 9 dpi [315]. Moreover, the impact of RNAi on arbovirus 
transmission remains obscure. 
 Accordingly, we sought to define how  the exo-siRNA pathway shapes the vector 
competence phenotype in mosquitoes and to determine whether the exo-siRNA pathway 
appears to be activated early during arbovirus infection when it may impact mosquito vector 
competence. Vector competence is a quantitative genetic trait under the control of several 
genomic loci which collectively account for a relatively small proportion of the observed 
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variation in vector competence phenotypes [426-428]. Thus, we hypothesized that quantitative 
and/or qualitative differences in the antiviral RNAi response in mosquitoes influence vector 
competence. Specifically, we profiled sRNAs in mosquito midguts at multiple time points and 
across infection phenotypes (midgut-limited infections and infections which had disseminated 
from the midgut into the hemocoel) in order to (1) track the development of the response and 
(2) determine whether specific viRNA profiles may be correlated with infection phenotype 
(midgut limited vs. disseminated). In addition, we also identified viRNA sequences common 
across multiple replicate libraries and time points and determined their individual efficacy in 
suppressing WNV replication in vitro. Our results suggest that RNAi is ineffective in limiting 
mosquito susceptibility to WNV infection because it is not activated during the first 24 hours of 
infection, when virus is entering cells and undergoing replication. Further, we failed to associate 
a particular profile of viRNA expression with either limitation of WNV to or its escape from 
mosquito midguts. In sum, these results fail to provide a strong link between RNAi and 
mosquito vector competence. 
 
Materials and Methods 
Mosquitoes 
Lab-colonized Cx. quinquefasciatus mosquito larvae (designated here as US-Cxq, 
described in [394]) were raised on a diet of a 1:1 mix of powdered Tetra food and powdered 
rodent chow. Pupae were allowed to emerge into containers and adult mosquitoes were kept 
at 26-27 ⁰C with a 16:8 light:dark cycle and 70%-80% relative humidity, with water and sucrose 
provided ad libitum. 
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Viruses and Experimental Infections 
WNV was produced from an infectious cDNA clone based on the WNVNY99 strain as 
previously described [397]. Briefly, purified viral RNA was electroporated into BHK-21 cells, with 
the electroporation parameters set to 425 V, 1200Ω resistance, 25µF capacitance, and two 
pulses. Cell supernatant was collected after cells showed obvious signs of cytopathic effect 
(CPE; usually ~3 days post-electroporation). Cellular debris was removed from the supernatant 
by centrifugation at ~3000 g, clarified supernatant was raised to a final concentration of 20% 
fetal bovine serum (FBS), and aliquots of 0.5 mL were made and stored at -80⁰C. Virus titer was 
then quantified by plaquing on Vero cells. Adult female mosquitoes 6-8 days post-eclosion were 
fed an infectious bloodmeal of de-fibrinated sheep blood mixed 1:1 with ~2 X 108 PFU/mL of 
infectious clone derived WNV (WNVicd). Un-infected control mosquitoes were fed only de-
fibrinated sheep blood. Engorged mosquitoes were held for 12 hour, 24 hour, 3 day, 7 day, or 
14/16 day extrinsic incubation periods (EIPs) in a BSL-3 insectary with the same rearing 
conditions described previously, after which they were cold anesthetized, and midguts 
dissected and stored in MagMax isolation lysis buffer (Ambion) at -80⁰C until needed for RNA 
isolation. Legs were also harvested from mosquitoes at 7, 14, and 16 days post infection (dpi) 
time points in order to assess for disseminated infections. 
 
Total RNA Isolation and Small RNA Library Preparations 
Total RNA was extracted from homogenized mosquito midguts and legs using the 
MagMAX Viral RNA isolation kit (Ambion) as per a modified protocol for enrichment of small 
RNA isolation in the total RNA fraction [429], using a Kingfisher Flex Magnetic Particle Processor 
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(Thermo Scientific, Waltham MA). Specifically, the incubation/binding time was increased from 
4 minutes to 10 minutes, and the amount of isopropanol added to Wash Buffer #1 was raised 
from 1:2 to 1:1. Eluted RNA from individual midguts and sets of 6 legs from each mosquito from 
each infection group and time point were screened for the presence of WNV genomic RNA by 
1-step RT-PCR (Qiagen) using 212-F (5’-TTGTGTTGGCTCTCTTGGCGTTCTT-3’) and 619-R (5’-
CAGCCGACAGCACTGGACATTCATA-3’) primers (numbers in primer designation denote genome 
position). Because accurate determination of infection (as measured by the presence of 
antisense viral RNA) is problematic at early time points, midguts from 12 and 24 hour time 
points were not screened for infection and simply designated as “exposed”. Since dissemination 
from the midgut would not be expected to occur by 3 dpi, we only screened midguts from this 
time point. For the 7, 14, and 16 dpi time points, an infection phenotype of “midgut-limited” 
was designated if no viral RNA was detectable in legs corresponding to a given midgut, and a 
“disseminated” phenotype was designated if viral RNA was detectable. Midgut RNA samples 
positive for viral RNA were checked for RNA quality on a 2100 Bioanalyzer (Agilent), and then 
pooled into groups of 5 midgut RNAs by infection phenotype and time point. Pooled RNAs were 
precipitated by adding 3.25 volumes of ice-cold EtOH, 0.1 volume 3M NaOAc (pH 5.5), and 1.5 
µL of linear polyacrylamide (5 mg/mL) as a carrier. After holding overnight at -20⁰C, the pools 
were centrifuged at ~20,000 g, washed twice with 80% EtOH, and re-suspended in nuclease-
free water. 1 µg total RNA was used as the input for small RNA library preparation using the 
TruSeq Small RNA Sample Prep Kit (Illumina) as per manufacturer’s suggested protocol. Briefly, 
small RNAs were preferentially 3’ and 5’ adapter-ligated, reverse transcribed using the 
Superscript II reverse transcriptase (Invitrogen), and PCR amplified, during which time a unique 
119 
 
oligonucleotide barcode sequence was added to each library for multiplexing. Three biological 
replicate libraries were made for each pooled time point/infection phenotype. In addition, we 
sequenced small RNAs from four separate individual midgut libraries at the 24 hour post-
exposure (hpe) time point. Small RNA libraries were size selected on 2% TBE-agarose gels, and 
purified with MinElute Gel Extraction kits (Qiagen). Purified small RNA cDNA libraries were 
eluted in Qiagen EB buffer, validated on the 2100 Bioanalyzer, and sequenced on an Illumina 
HiSeq 2000 instrument. 
 
Assembly and Analysis of sRNA Libraries 
Sequence FASTQ files were trimmed of the 3’ adapter using FASTX Toolkit [400] and 
aligned to the WNVNY99 infectious clone reference sequence using Bowtie 0.12.8 [401] and 
allowing for 0-mismatches. The -a --best --strata mode was used, which instructs Bowtie to 
report only those alignments in the best alignment stratum. SAM output files produced by 
Bowtie were used as the input for processing through SAMtools [402]. Nucleotide targeting 
plots of the viral genome were generated using the pileup function of SAMtools, and then used 
for correlational analysis. Additional analyses were conducted using Microsoft Excel, Graphpad 
Prism 6, and VENNY, an online tool for creating Venn diagrams [430].  
 
Transfection of C6/36 Mosquito Cells with Synthetic siRNAs 
Ae. albopictus-derived C6/36 cells were seeded into 6-well plates at a concentration of  
1 X 106 cells/well, and transfected one day later with 100 pM concentration of synthetic siRNA 
duplexes (Dharmacon, Inc., Lafayette CO, siRNA sequences provided in Table 4.1) using 
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Lipofectamine 2000 transfection reagent (Invitrogen, Carlsbad CA) as per manufacturers 
suggested protocol. Cells were infected 48 hours post-transfection with infectious clone derived 
WNVNY99 at an MOI of 0.1. 300 µL of cell supernatant was harvested every 12 hours up to 48 hpi 
and viral titer quantified by plaque assay on Vero cells.  
 
qRT-PCR 
WNV genome equivalents were determined using a Taqman qRT-PCR assay amplifying a 
70bp fragment within the WNV E gene (described in [404]). 5 µL of total RNA from individual 
mosquito midgut samples used to construct our small RNA sequencing libraries or genome 
equivalent standards was used as the template in duplicate 20 µL reactions using the iScriptTM 
1-Step RT-PCR Kit for probes (Biorad) with reagent ratios as per the manufacturer’s suggested 
protocol. The following primer and probe sequences were used for this assay: 1160-F (5’-
TCAGCGATCTCTCCACCAAAG-3’), 1229-R (5’-GGGTCAGCACGTTTGTCATTG-3’), and 1207-Probe 
(5’-TGCCCGACCATGGGAGAAGCTC-3’). Reactions were run on a CFX-96TM real-time system 
(Biorad). WNV genomic equivalent standards were previously generated by amplifying a 2.4 kb 
fragment from the WNV E gene using WNV 1031-F (5’-ATTTGGTTCTCGAAGGCGAC-3’) and WNV 
3430-R (5’-TGGTGGTAAGGTGCAGCTCC-3’) primers. The resulting amplicon was then cloned 
into the pCR2.1-TOPO vector (Invitrogen) downstream of the T7 promoter. The recombinant 
vector was linearized with KpnI, purified and used as template for in vitro transcription using 
the T7 Megascript kit (Ambion) according the manufacturer’s instructions. In vitro transcribed 





The exogenous siRNA and PIWI-interacting RNA (piRNA) pathways do not appear to be 
induced at early time points of WNV infection 
We sequenced small RNAs from triplicate pools of 5 Cx. quinquefasciatus midguts from 
early (12 hpe, 24 hpe, and 3 dpi) and late (7 dpi, 14 dpi, and 16 dpi) time points after infection 
with WNV. The percentage of reads mapping to WNV RNA varied considerably between time 
points, but was relatively consistent between replicates (Figure 4.1A). At 12 hpe, few viRNA 
reads were present, however the percentage of viRNAs relative to total 19-30 nt small RNAs 
increased considerably by 24 hpe. At 3 dpi, detectable viRNAs had again dropped to 
proportions comparable to the 12 hpe time point, and gradually increased by 7, 14, and 16 dpi. 
Analysis of the distribution of sequences by length revealed that 19-30 nt reads mapping to the 
WNV genome were approximately evenly distributed with no peak at 21 nts, which would be 
expected from products of Dcr-2 digestion (Figure 4.1B-C). Viral replication at these early time 
points was evident based on the presence of a significant fraction of viRNAs derived from the 
negative strand of the virus RNA. Bias for reads derived from the positive strand of the virus 
was elevated at 12 hpe compared to the later time points, with roughly 80% of 19-23 nt reads 
being generated from this strand (Figure 4.2A). In contrast, 19-23 nt viRNAs were more or less 
equally generated from both the positive and negative strands at all other time points during 
infection. Strand biases for 24-30 nt sequences, which correspond by size to products of the 
piRNA pathway, were more skewed toward the positive strand (Figure 4.2B). At 12 hpe, roughly 
75% of 24-30 nt reads mapping to WNV were derived from the positive strand. At 24 hpe, the 
ratio of positive:negative strand had decreased to ~60:40, inconsistent with the heavy positive-
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strand bias observed in our previous studies as well as the published literature [282, 313, 318, 
316, 314]. The expected positive-strand bias began to resolve starting at 3 dpi onward, with 
~80-90% of 24-30 nt reads being derived from the positive strand at these time points (Figure 
4.2B). Interestingly, 24-30 nt small RNAs were significantly enriched in the 14 dpi midgut limited 
cohort as compared to the 16 dpi disseminated cohort (Figure 4.1F). This population of small 
RNAs represented between 7% and 20% of the total 19-30 nt RNAs across replicates in this 
cohort. However, 24-30 nt small RNAs in the 7 dpi midgut limited cohort were not significantly 
enriched over the 7 dpi disseminated group (Figure 4.1E). Starting at 3 dpi, the size distribution 
of 19-23 nts RNAs became approximately normally distributed with a prominent peak at 21 nts 
(Figure 4.1C-F).  
 
Nucleotide targeting of the virus genome by RNAi is highly conserved within and between 
time points and infection phenotypes 
 We previously compared intra- and interspecies anti-WNV RNAi profiles across different 
species and populations of mosquitoes, and found that in particular, the relative intensity of 
intra-species nucleotide targeting of the virus genome was highly conserved. We compared the 
19-23 nt viRNA nucleotide targeting profiles of midgut pools sequenced in triplicate at 3 dpi, 
7dpi, 14 dpi, and 16 dpi. The 7 dpi and the 14-16dpi time points were classified into two 
different infection phenotypes: midgut limited and disseminated, determined by either the lack 
or presence of detectable viral RNA in the legs, respectively.  
 To test the hypothesis that qualitative and/or quantitative differences in targeting of the 
viral genome by the exo-siRNA pathway influences vector competence, we correlated 
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nucleotide targeting frequencies between individual replicates within a cohort (i.e. 7 dpi midgut 
limited) and between cohorts (i.e. 7 dpi midgut limited vs. 7dpi disseminated). We focused on 
the 19-23 nt reads corresponding to products of the siRNA pathway since this population makes 
up the bulk of the total RNAi response. At 12 hpe, there was a low correlation between 
replicates as measured by the Spearman r value (rs= 0.31) (Figure 4.3). In contrast, at 24 hpe, 
intra-time point replicates were more strongly correlated (rs=0.77). Similar results were 
observed for intra-time point and intra-infection phenotype correlations for 7, 14, and 16 dpi. 
Surprisingly, when we made inter-time point and inter-infection phenotype comparisons 
between individual replicates at 3 dpi, 7 dpi, 14 dpi, and 16 dpi, the strength of the correlation 
in all cases was statistically equal to the intra-cohort comparisons within replicates. Similarly, 
the ratio of small 19-23 nt viRNAs derived from either the positive or negative strand across 
these time points did not change significantly (Figure 4.2A). This suggests that once the RNAi 
pathway is activated, the relative intensity of nucleotide targeting of the virus genome (i.e. the 
“RNAi profile”) remains constant during the course of infection.  
 We next measured viral load in individual mosquitoes comprising each replicate pool 
from 3 dpi to 16 dpi using qRT-PCR. There was no association between viral genome copy 
number and infection phenotype. When comparing both the 7 dpi midgut limited vs. 
disseminated libraries and the 14-16 dpi midgut limited and disseminated libraries, titers were 
higher in the midgut limited libraries when comparing either individual replicate titers or cohort 




Abundant viRNAs are inefficient at individually suppressing WNV replication in C6/36 
mosquito cells 
We next tested whether abundant viRNAs from early (12 hpe, 24 hpe) and later (7 dpi) 
time points could effectively suppress WNV replication in vitro. We identified several highly 
abundant viRNAs common to both the 12 and 24 hpe libraries, as well as viRNAs common 
amongst the 7 dpi libraries. We designed synthetic siRNA duplexes to each of these selected 
viRNA sequences and individually transfected them into Ae. albopictus-derived C6/36 cells 48 
hours prior to infecting with WNV. With the exception of siRNA 7d at 48 hours post infection 
(hpi), none of the siRNAs significantly reduced viral titers individually (Figure 4.5). The 
combined effect of these siRNAs was not determined. 
 
Discussion 
In this study, we sought to determine the temporal plasticity of the anti-WNV RNAi 
response in Cx. quinquefasciatus mosquitoes, as well as determine the effect of the exo-siRNA 
pathway in shaping mosquito vector competence to arbovirus infection. At early time points 
after taking an infectious bloodmeal, small RNAs sequenced from the midguts of WNV-exposed 
mosquitoes exhibited an atypical size distribution profile, specifically lacking a prominent peak 
at 21 nts, which is a hallmark of the Dcr-2 mediated siRNA response. Since we lacked the ability 
to reliably determine prior to sequencing whether these mosquitoes had replicating virus in the 
midgut, mosquitoes pooled for small RNA libraries at the 12 and 24 hpe time points were 
deemed as “exposed” as opposed to “infected”. However, small RNA sequencing revealed 
sequences derived from the negative strand of the virus, indicating active viral replication. A 
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key question that remains is biogenic origin of the small RNA sequences from these early time 
points. It is possible that we were observing the early stages of the siRNA response, prior to the 
development of the stereotypical normal distribution with a peak at 21 nts that has been 
observed in ours and others’ previous studies of invertebrate RNAi responses to RNA viruses 
[280, 282, 283, 293, 313, 281, 314-318, 431-433]. Conversely, it is also possible that we were 
sequencing degradation products produced by other cellular non-RNAi RNA decay pathways. 
The latter scenario seems to be supported by our observations at the 12 hpe time point, since 
the low correlation of nucleotide frequency within the reads between replicates may be 
indicative of the “random” production of RNA products, such as through the incomplete exo-
nucleolytic degradation by XRN-1 or the exosome. The Illumina Truseq small RNA protocol we 
used to make our sequencing libraries is designed to specifically ligate RNAs with a 5’-PO4 and 
3’-OH, which miRNAs, siRNAs, and piRNAs all exhibit, and the size selection step of the protocol 
ensures a further degree of specificity for small RNA products. However, it is possible that in the 
absence of appreciable amounts of small RNAs, other RNA products can become preferential 
targets for adapter ligation and subsequent sequencing.  In mammals, Dicer has been shown to 
cleave targets with high specificity with regards to RNA secondary structure and distance from 
the 5’-end of the target [434, 435]. It is likely that invertebrate Dicer enzymes similarly 
recognize signatures in their targets that dictate where cleavage of the target occurs. Indeed, 
the high degree of intra- and inter-cohort correlation we see between replicates suggests that 
targeting and subsequent processing of the virus genome by Dcr-2 is not random, but highly 
specific. Due to the atypical proportions of 24-30 nt RNAs to 19-23 nt RNAs, the apparent lack 
of consistency in nucleotide targeting between replicates at 12 hpe, and the lack of expected 
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strand bias at 12 and 24 hpe in the 24-30 nt RNAs, we conclude that neither the siRNA nor 
piRNA pathways are activated at the earliest, and probably most relevant timepoints during 
mosquito infection.  
By 3 dpi infection, a more stereotypical distribution of viRNAs had appeared, with a 
prominent peak at 21 nts, indicative of Dcr-2-mediated digestion of the virus genome. There 
was no statistical difference in the proportions of 19-23 nt viRNAs between replicates or 
infection phenotypes at any time point; however, at 14 dpi, there was a statistically significant 
enrichment of 24-30 nt viRNAs in the midgut limited vs. the 16 dpi disseminated group. An 
enrichment in this size class, which corresponds to products of the piRNA pathway, was not 
observed between 7 dpi midgut limited and disseminated cohorts. There is a considerable lack 
of understanding regarding the impact the piRNA pathway has on controlling arbovirus 
infection, and we hypothesize in the previous chapter that it plays a compensatory or 
redundant rather than a primary role in RNAi-mediated antiviral defense. 
 In this study, we hypothesized that qualitative or quantitative differences in the RNAi 
response may be correlated with vector competence phenotypes in the mosquito midgut; 
specifically, whether or not the virus is restricted to the midgut epithelium or is allowed to 
disseminate into distal tissues. Surprisingly, we not only found that once established, the 
antiviral RNAi profile in mosquito midguts is remarkably constant during the entire course of 
infection, but that there was little discernable difference in the profiles of midguts from 
mosquitoes with disparate infection phenotypes. There are several possibilities for this 
observation. First, these experiments were carried out using highly inbred, colonized 
mosquitoes with presumably low genetic diversity. While Dcr-2 has been shown to undergo 
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rapid evolution in mosquitoes and is correlated with differential vector competencies to virus 
infection [407, 408], it is unlikely our colonized mosquitoes undergo such selective pressures, 
since infected mosquitoes are not part of the breeding stock of the colony. Additionally, it is 
unknown what phenotypic effect on the targeting specificity of Dcr-2 may occur as the result of 
mutation within that gene. Vector competence is a polygenic trait that is not completely 
understood, and it is likely that many factors, both internal and external, contribute to the 
vector competence phenotype in mosquitoes. It is also possible that by limiting our studies to 
the mosquito midgut, we may have missed important variation in the RNAi response in other 
tissues; i.e. is a midgut-limited phenotype due to the strict inability of the virus to escape from 
the midgut, or can a robust RNAi response in the hemolymph (perhaps primed by a 
hypothetical systemic RNAi response) of the mosquito clear or prevent infection in that 
compartment. We found no relationship between the viral load in mosquito midguts and the 
infection phenotype; in fact, mosquitoes with disseminated infections had slightly lower virus 
genomic copy numbers than mosquitoes with midgut limited infections, though this difference 
was not statistically significant. Thus, we conclude that not only does the antiviral RNAi 
response fail to limit viral load in midgut limited versus disseminated infection phenotypes, but 
that it is not associated with either the restriction or dissemination of the virus from the 
midgut.  
 We also investigated the individual efficacy of highly abundant viRNAs from our 
sequencing data in limiting WNV replication in vitro. In congruence with previous unpublished 
data from our lab, we found that at best, there was modest suppression of WNV replication in 
C6/36 cells infected with WNV 48 hours post transfection with synthetic siRNAs. A single siRNA 
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at 48 hpi showed statistically significant suppression of WNV as measured by Dunnett’s 
multiple comparisons test. A relatively recent paper demonstrated that low abundance Semliki 
Forest virus (SFV, Togaviridae)-derived viRNAs were more effective at suppressing virus 
replication than highly abundant viRNAs in Ae. albopictus-derived U4.4 and Ae. aegypti-derived 
Aag2 cells [433]. However, previous unpublished work from our lab has shown that synthetic 
siRNAs designed from low abundance WNV-derived viRNAs were no more effective at 
suppressing viral replication than highly abundant viRNAs. Thus, susceptibility to replicative 



























siRNA Name Sense Sequence Antisense Sequence 
1224a 5’-GGCACCAGAGCCCGAGUCAUU-3’ 5’-UGACUCGGGCUCUGGUGCCUU-3’ 
1224b 5’-ACUUCCCGGCCUGACUUUCUU-3’ 5’-GAAAGUCAGGCCGGGAAGUUU-3’ 
1224c 5’-CUUCCCGGCCUGACUUUCUUU-3’ 5’-AGAAAGUCAGGCCGGGAAGUU-3’ 
1224d 5’-CUCCUCCAACUGCGAGAAACGUGUU-3’ 5’-AGAAAGUCAGGCCGGGAAGUU-3’ 
1224e 5’-GCUCUAAUUCUGGGACGUCCGUU-3’ 5’-CGGACGUCCCAGAAUUAGAGCUU-3’ 
7a 5’-GGUGCGAGUGGCAGGUCCACGUU-3’ 5’-CGUGGACCUGCCACUCGCACCUU-3’ 
7b 5’-CAGCGAACUGGCGGAGCCUGUUU-3’ 5’-ACAGGCUCCGCCAGUUCGCUGUU-3’ 
7c 5’-GACUUACAGACUGAGAUCCCGUU-3’ 5’-CGGGAUCUCAGUCUGUAAGUCUU-3’ 
7d 5’-GACAGUACGAGAAGCCGGAAUUU-3’ 5’-AUCCGGCUUCUCGUACUGUCUU-3’ 
7e 5’-GGCAGUCCUCUCAGUGCUUCAUU-3’ 5’-UGAAGCACUGAGAGGACUGCCUU-3’ 
Table 4.1: Sequences for synthetic siRNAs transfected into C6/36 mosquito cells 
prior to WNV infection. The number designation in the name denotes the libraries 
these sequences were identified from, i.e. 1224 indicates that these sequences were 
abundant in both 12 and 24 hpe libraries, 7 means that these sequences were 
abundant amongst the 7 dpi libraries. The two terminal U’s at the 3’ end of each 
sequence (underlined) are artificial 3’-overhangs inserted to mimic the 2 nt 3’ 











Figure 4.1: Features of small RNA libraries. A) Relative abundance of small 
RNA reads mapping to the WNV genome normalized per million. Error bars 
represent mean and SEM. B-F) Distribution of viRNA sequences by size at 12 
hpe (B), 24 hpe (C), 3 dpi (D), 7 dpi (E), and 14/16 dpi (F). Mean values of 3 
replicates are plotted, error bars represent SEM. Asterisk in (F) denotes 
significant difference in 24-30 nt abundance by an unpaired t-test with 







Figure 4.2: Positive/negative strand ratios for small RNA libraries. A) 19-23 nt reads, B) 
24-30 nt reads. Mean values for three replicates from each cohort are plotted. Error bars 































































































































































































































































































































Figure 4.4: WNV genome equivalents from library pools as measured by qRT-
PCR. Taqman qRT-PCR was performed on individual mosquito midguts used to 
create small RNA library pools. A) WNV genome equivalents/µL total RNA for 
individual mosquitoes from each replicate within the 3 dpi, 7 dpi, 14 dpi, and 16 
dpi cohorts. Bars represent mean and SEM. B) Mean genome equivalent titers 
for each replicate. Bars represent mean and SEM. For both graphs, statistically 
homogeneous data sets share common letters. Statistical significance (p≤ 0.05) 
was determined by log10 transforming the data and then performing Tukey’s 












Figure 4.5: Synthetic siRNA transfection of C6/36 cells. C6/36 
cells were transfected with synthetic siRNA duplexes 48 hours 
prior to infection with WNV. Cell supernatant was harvested every 
12 hours up to 48 hpi and viral titers quantified by plaque assay. 
Mean titers of three replicates are plotted, error bars represent 
SEM. Asterisk denotes WNV titer from the 7d siRNA treatment 
group at 48 hours which was significantly less than the negative 
siRNA control (siNEG) as determined by Dunnett’s multiple 
comparisons test (p≤ 0.05). 
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Arboviruses constitute both emerging and re-emerging threats to human and livestock 
health worldwide. In particular, mosquito-borne arboviruses cause the majority of severe 
disease outbreaks. It is therefore critical that we develop a complete understanding of 
mosquito-virus interactions, both from macro (i.e. natural history, ecology, etc.) and molecular 
(i.e. virus evolution, vector innate immunity) perspectives. Additionally, a detailed 
understanding of these factors is important in order to ascertain how they influence differences 
in susceptibility to arbovirus infection and likelihood of transmission in natural populations of 
mosquitoes, i.e. vector competence. 
 RNAi is the major innate immune response to arbovirus infection in mosquitoes [383]. 
Over a decade of research has been invested into investigating the role small RNA pathways 
play in controlling arbovirus infection in mosquitoes. What has become clear is that RNAi, 
specifically the exo-siRNA pathway, protects mosquitoes from lethal infection [388], and data 
from other infection models suggest that an equilibrium between the antiviral-RNAi response 
and viral replication allows for the establishment of a persistent, non-pathogenic infection 
[297]. Insights into the importance of the antiviral function of small RNA pathways have 
inspired research into the development of novel arbovirus control strategies which seek to 
exploit these immune pathways [385, 18, 20, 387, 386]. However, there is still a considerable 
lack of understanding regarding the degree to which the antiviral RNAi response varies amongst 
mosquito species and populations, as well as how it influences mosquito vector competence. 
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Additionally, it has only been recently that the role of another small RNA pathway, the piRNA 
pathway, has been implicated in participating in antiviral defense in mosquitoes. 
 The work contained in this dissertation sought to resolve these questions and increase 
our understanding of small RNA pathways in the context of innate immunity to arboviruses in 
mosquitoes. We first began by profiling virus-derived small RNAs in the midguts of Culex sp. 
mosquitoes in response to WNV infection using the Illumina next-generation sequencing 
technology. The midgut is the first site of infection after imbibing an infectious bloodmeal, and 
a failure to infect/replicate sufficiently/disseminate from this tissue results in a dead-end 
infection for the virus. Since there is a lack of studies that have investigated innate immune 
mechanisms in natural populations of mosquitoes to arbovirus infection, we collected egg rafts 
from three species of WNV vector mosquitoes from the field: Cx. quinquefasciatus, Cx. pipiens, 
and Cx. tarsalis. We reared larvae to adulthood in the laboratory, and experimentally infected 
adult female mosquitoes per os with an infectious clone derived virus based on the NY99 strain 
of WNV. We then compared viral-derived small RNA populations of 19-30 nts sequenced from 
midgut pools of infected mosquitoes. In addition, we sequenced midgut pools from colonized 
Cx. quinquefasciatus, Cx. tarsalis, Cx. pipiens, and Ae. aegypti mosquitoes reared and infected in 
the same manner. We found that there was a high degree of intra-species correlation between 
the 19-23 nt viRNAs (consistent in size with products of the Dcr-2 dependent exo-siRNA 
pathway) in all of the species studied. We also made interspecies comparisons between WNV-
derived viRNAs and found a striking level of correlation between species; with the notable 
exception of Cx. quinquefasciatus, which significantly differed in the targeting of the virus 
genome when compared to Cx. tarsalis, Ae. aegypti, and even the closely related sister taxa Cx. 
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pipiens. Previous work has shown that WNV undergoes population bottlenecks in Cx. pipiens 
[405], but not Cx. quinquefasciatus [406]. It is therefore possible that qualitative differences in 
the total RNAi response may differentially influence virus diversification and population 
structure. As we did not analyze virus genetic diversity from our sequenced mosquitoes, it is 
impossible to draw a correlate; however, future studies should address this point. 
 While profiling 19-30 nt viral-derived small RNAs from both field-collected and colonized 
Cx. quinquefasciatus mosquitoes, we found that while the relative proportion of 19-23 nt did 
not differ statistically between the groups, the proportion of 24-30 nt small RNAs, 
corresponding in size to products of the piRNA pathway, did differ significantly across the three 
groups. The piRNA pathway is a relatively recently described small RNA pathway that plays 
important roles in spermatogenesis [301] in flies, and is an important suppressor of 
transposable elements in gametic tissue [301]. Endogenous piRNAs typically exhibit strong 
strand biases, being primarily antisense to TE’s [305], and exhibit preferences for a 5’-uracil 
residue on primary piRNAs and an adenosine at position 10 of secondary piRNAs [311, 312]. The 
ping-pong dependent amplification model has been proposed to explain these nucleotide 
biases. Recently, the piRNA pathway has been implicated in participating in antiviral defense in 
flies and mosquitoes [282, 313, 281, 314-318] Moreover, when we analyzed the strand bias and 
nucleotide bias for these small RNAs in all of our Culex and Ae. aegypti libraries, we found a 
very strong bias for reads derived from the positive strand of the virus; however, no preference 
for a U1 residue on the primary (negative) strand or a A10 on the secondary strand (positive) was 
observed in these putative viral-derived piRNA-like small RNAs (vpiRNAs). This is partially 
consistent with what has been observed for DENV-2 in both mosquitoes and mosquito cells 
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[315, 281], for which only a slight bias for an A10 was observed, but contrary to what has been 
observed in alphavirus and bunyavirus infected mosquitoes or mosquito cells, where viral-
derived piRNAs (vpiRNAs) consistent with the model for ping-pong dependent amplification 
have been sequenced [317, 282, 313, 318, 316]. Therefore, we hypothesized that infection with 
either alphaviruses or flaviviruses results in the disparate biogenesis and/or processing of small 
RNAs through the piRNA pathway.  
We chose Cx. tarsalis, an important natural vector for both WNV and WEEV, and a 
competent laboratory vector for SINV, as our single-species infection model, and sequenced 
both midguts and carcasses sans ovaries from mosquitoes experimentally infected with these 
viruses. Remarkably, we found that infection with none of these viruses resulted in production 
of 24-30 nt small RNAs with signatures of ping-pong dependent amplification. Additionally, we 
found that while a strong bias for reads being derived from the positive strand of the virus was 
maintained in both midguts and carcasses of mosquitoes infected with WNV, only the carcasses 
of mosquitoes infected with either WEEV or SINV exhibited a strong positive strand bias. This 
observation challenged our hypothesis that production of 24-30 nt small RNAs that either 
exhibited signatures of ping-pong dependent amplification or did not was virus dependent. 
When we analyzed a previously made library from Ae. aegypti infected with SINV, we found 
that a strong positive strand bias was maintained, along with the expected nucleotide biases 
observed for other alphavirus infections in Ae. spp. mosquitoes and cells. However, Ae. aegypti 
does not produce piRNA-like small RNAs with these molecular signatures to WNV. Therefore, 
we concluded that the specific products of the piRNA pathway in mosquitoes are dependent on 
both host and virus, and that specific viruses do not universally elicit production of ping-pong 
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dependent piRNA-like small RNAs, nor do specific vectors universally produce ping-pong 
dependent piRNA-like small RNAs to arbovirus infection. 
 We were able to confirm the presence of transcripts for required machinery for the 
ping-pong dependent pathway in Cx. quinquefasciatus midguts, providing evidence that it is 
likely this pathway is functional in this tissue. Secondly, we aligned small RNA reads to several 
selected TE sequences from Cx. quinquefasciatus, finding not only that they exhibited strong 
strand bias (antisense to the TE), but also the expected nucleotide bias. This implies that the 
pathway is intact in Cx. quinquefasciatus (and presumably Cx. pipiens and Cx. tarsalis), but for 
currently unknown reasons, is not triggered by arbovirus infection. 
 The role of RNAi in influencing the vector competence phenotype in mosquitoes is 
poorly understood. We do know that vector competence is a quantitative genetic trait, under 
the control of several loci [426-428] ; however, collectively, these loci account for little of the 
wide variation in observed vector competence phenotype amongst species and populations 
within species. Therefore, we hypothesized that since RNAi is the major innate immune 
pathway responsible for controlling arbovirus infection in mosquitoes, it also plays a role in 
shaping the vector competence of the insect. Using multiple biological replicates, we profiled 
the midgut small RNA response to WNV infection in our colonized Cx. quinquefasciatus 
mosquitoes at both early (12 hpe, 24 hpe, 3 dpi) and late (7 dpi, 14/16 dpi) time points as well 
as different infection phenotypes (midgut limited and disseminated). Remarkably, we found 
little evidence for activity of the siRNA or piRNA pathways at 12 hpe and 24 hpe, though by 3 
dpi, products of Dcr-2 dependent digestion of the virus genome were evident. Additionally, we 
found no correlation between a particular viRNA profile and either limitation to or escape from 
140 
 
the midguts of infected mosquitoes. Moreover, neither infection phenotype nor RNAi profile 
was correlated with virus load in the midgut. Based on these lines of evidence, we conclude 
that RNAi fails to control virus replication at key time points during infection, specifically, when 
the virus is first entering cells and undergoing replication.  
 Taken together, these investigations into the antiviral RNAi pathways in mosquitoes to 
arbovirus infection add to the continually growing body of evidence highlighting the importance 
of small RNA pathways in controlling arbovirus infection. However, there are numerous 
unanswered questions that remain ripe for exploration. For example, little is known about the 
effect persistent viral infection has on altering the RNAi response in natural populations, where 
vertical (transovarial) transmission of arboviruses, in particular bunyaviruses, is possible [436, 
186, 437]. Bombyx mori larvae are frequently persistently infected with Bombyx mori 
cytoplasmic polyhedrosis virus (BmCPV, Reoviridae) [438], and have been found to have 
frameshift mutations in r2d2, a core component of the siRNA pathway [439]. Similarly, virus 
infection has been correlated with deficiencies in RNAi in C. elegans [440]. This has led to the 
hypothesis that persistent infection leads to the alterations in the RNAi response in insects 
[438]. Whether the RNAi response is similarly altered by arboviruses in mosquitoes is 
undetermined. Another interesting avenue of future research would be the existence of a 
mechanism for systemic RNAi in mosquitoes, such as that described in Drosophila [292]. Future 
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